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RNA modifications have been known to exist since the late 1960s, but the 
methods to detect them globally did not exist until recently. The release of an 
antibody specific to the RNA modification methyl-6-adenosine (m6A) enabled its 
transcriptome-wide mapping sites using MeRIP-Seq, a variation of RIP-seq that 
enriches for RNA fragments using the antibody in a pulldown assay and 
identifies them using next-generation sequencing. The dynamic 
epitranscriptome has the potential to be involved in multiple layers of regulation, 
from translation repression to nuclear export and splicing. The purpose of this 
dissertation was to develop methods both experimentally and computationally 
to map and identify m6A sites. As a dynamic modification, m6A and other RNA 
modifications change in frequency in response to cell stress and stimuli. 
Developing methods to detect these changes further elucidate its functional 
role. 
First, the limitations of the MeRIP-Seq protocol were demonstrated, from its 
input requirements to the consequences of batch effects, ribosomal RNA 
contamination, and IP efficiency. Second, computational methods were 
developed to analyze MeRIP-seq data, implementing MeRIPPeR as an m6A 
peak finder that performs with higher sensitivity than other peak finders. The 
consequences of choice of aligner and annotation were also discussed, as well 
as methods to correct for technical variation and batch effects introduced during 
the MeRIP-seq protocol. Third, additional computational methods were 
 developed to identify changes in methylation sites, identifying differentially 
methylated peak regions to unravel the dynamics of m6A. 
These three methods were then applied to two case studies. In the first study, 
changes in m6A sites in response to heat shock and ribavirin treatment in the 
context of nuclear export were examined. The results showed a correlation 
between differentially methylated peak regions in introns and changes in 
nuclear/cytosolic ratios. The second study explored m6A’s role in adipogenesis 
in the porcine model, serving as the first study of m6A in pigs. Differentially 
methylated peak regions found in both studies implicate dynamic m6A sites in 
genes involved in RNA regulation, splicing, and nuclear export pathways. The 
results demonstrate the biological importance of m6A and further implicate it in 
RNA processing and regulation.  
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CHAPTER 1 INTRODUCTION TO METHYL-6-ADENOSINE 
1.1 Background 
Although RNA modifications have been known to exist for many years, only 
recently have new assays and high-throughput sequencing technologies 
enabled the characterization of these modifications across the transcriptome. 
This not only opened the door to examining the physiological and functional role 
of these modifications, but also their importance in the context of diseases and 
development.  
1.1.1 “The Birth of the Epitranscriptome”  
Francis Crick theorized the Central Dogma of Molecular Biology in 1956 to show 
the flow of genetic information, as DNA is transcribed into RNA and the RNA is 
translated into proteins. This somewhat simple view ignores the multiple layers 
of regulation and interaction between the three layers, such as chromosomal 
recombination in DNA, transcription factors and promoters in transcription 
regulation, and micro-RNAs (miRNAs) in translation suppression. The term 
epigenetics was first used in 1942 by C. H. Waddington, but its usage has now 
evolved to refer to the modifications and structure of DNA, a layer “on top” (epi) 
of the mutations that can occur in the actual DNA bases. This includes the 
chromatin structure of DNA, histone modifications such as H3K4 mono-
methylation and tri-methylation, and DNA modifications like 5-methylcytosine 
(5mC) and 5-hydroxymethylcytosine (5hmC). 
Although the first RNA modifications were discovered in the late 1960s, the 
inability to map them transcriptome-wide hindered research.  (Iwanami and 
Brown, 1968) The five-prime cap on mRNA, a methylated guanosine, or 7-
methylguanylate, was discovered to regulate nuclear export  (Lewis and 
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Izaurralde, 1997; Visa et al., 1996) and prevent degradation by 
exonucleases  (Burkard and Butler, 2000; Evdokimova et al., 2001; Gao et al., 
2000). Initial studies of the most prevalent mRNA modification, N-6-
methyladenosine, or methyl-6-adenosine (m6A) (Figure 1.1), utilized 14C-
radiolabeled methionine to observe its incorporation into RNA methyl groups 
through the endogenous methyl donor, S-adenosylmethionine. They discovered 
m6A was present in ribosomal RNA (rRNA) (Iwanami and Brown, 1968), small 
RNA fractions (Bringmann and Luhrmann, 1987; Desrosiers et al., 1974; 
Epstein et al., 1980; Levis and Penman, 1978; Wei et al., 1976), and 
mRNAs (Horowitz et al., 1984).  
 
Figure 1.1: Methyl-6-Adenosine (m6A)  
Methyl-6-adenosine with methyl group highlighted in red. Adapted from  (Li and 
Mason, 2014).  
Examination of specific methylation sites were restricted to bovine 
prolactin  (Chen-Kiang et al., 1979) and the Rous sarcoma virus  (Beemon and 
3 
Keith, 1977; Kane and Beemon, 1985). Few groups were interested in m6A until 
recently when the fat mass and obesity-associated (FTO) gene was discovered 
to also be one of the demethylases of m6A.  (Jia et al., 2011) Variants of FTO 
had previously been linked to obesity  (Frayling et al., 2007; Yang et al., 2012) 
and also Alzheimer’s disease  (Benedict et al., 2011; Keller et al., 2011), 
bringing new attention to an almost forgotten field.   
An antibody specific to m6A was developed in 1977 by Synaptic Systems but 
was not made publicly available until recently.  (Munns et al., 1977) Following 
its release, New England Biolabs also made their m6A antibody publicly 
available  (Kong et al., 2000), and now at least five such antibodies have been 
developed by multiple companies. In collaboration with Kate Meyer, PhD, and 
Samie Jaffrey, MD PhD, we developed MeRIP-Seq, methylated RNA 
immunoprecipitation sequencing, to identify m6A sites throughout RNA. Similar 
to ChIP-Seq (chromatin immunoprecipitation sequencing), the antibody is used 
to pulldown and enrich for RNA fragments containing m6A, which are then 
identified using next-generation sequencing. By comparing the enrichment of 
these fragments to an RNA-Seq control, putative m6A peak regions can be 
identified. With the establishment of this protocol, m6A could now be studied 
transcriptome-wide. 
This heralded “the birth of the epitranscriptome,”  (Saletore et al., 2012) a new 
portmanteau we coined to encompass the new field of RNA modifications. 
Previously, groups had struggled with non-specific phrases like “RNA 
methylome”  (Dominissini et al., 2012) or “RNA epigenetics,”  (He, 2010) neither 
of which we felt fully encapsulated the new field. Although at the time we meant 
it to refer to all RNA modifications, our focus remained on m6A. However, the 
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field itself has grown to now include transcriptome-wide 5-methylcytosine 
mapping in RNA. Utilizing the same bisulfide treatment used in DNA to identify 
5mC sites  (Meissner et al., 2005), 5mC was successfully mapped in mRNAs 
and found to be enriched near Argonaute binding regions. (Squires et al., 2012) 
In total, the epitranscriptome has the potential to encompass all of the over 100 
RNA modifications listed in the RNA Modifications Database,  (Agris et al.; 
Cantara et al., 2011) but only a small fraction can be mapped across the entire 
transcriptome, at present.  However, it should be noted that there is a new focus 
on pseudouridine,  (Jaffrey, 2014) the most prevalent RNA modification and the 
C-glycoside isomer of uridine. Mostly found in tRNAs, new technologies such 
as Pseudouridine-Seq  (Schwartz et al., 2014) continue to grow the world of the 
epitranscriptome.  
1.1.2 The History of Methyl-6-Adenosine 
N6-methyladenosine, also referred to as methyl-6-adenosine or m6A, is the 
addition of a methyl-group onto the sixth nitrogen of adenosine in RNA. The 
modification was first discovered in 1968 in rRNAs.  (Iwanami and Brown, 1968) 
Initial studies identified the modification in viruses  (Moss et al., 1977), 
yeast  (Bodi et al., 2010) and corn,  (Nichols, 1979) with following studies on 
yeast in 2002 looking at the potential for the dynamic nature of m6A  (Clancy et 
al., 2002). The majority of m6A sites can be found in mRNAs and long non-
coding RNAs, but recently they have also been identified in the far smaller micro 
RNAs (miRNAs).  (Berulava et al., 2015) 
1.1.3 The Dynamic World of Methyl-6-Adenosine 
As m6A and other epitranscriptomic modifications are co-transcriptionally or 
post-transcriptionally added, they have the potential to be a dynamic level of 
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regulation, changing in response to cell stimuli and stresses. The 
methyltransferase of m6A, or the protein responsible for methylating adenosine 
to m6A, was first identified in 1997 by Bokar et al (Bokar et al., 1997) to be 
METTL3, also known as MT-A70. Subsequently, the methyltransferase complex 
was discovered to include METTL14 (Liu et al., 2014) and WTAP (Ping et al., 
2014). The FTO gene was first identified as a demethylase of m6A in 2011,  (Jia 
et al., 2011) followed by ALKBH5 in 2013.  (Zheng et al., 2013) Knockdown 
experiments of METTL3 in HeLa cells led to apoptosis, (Dominissini et al., 2012) 
demonstrating the physiological significance of m6A. Initial studies in m6A also 
identified a sequence specificity for METTL3, as the RRACH consensus, or 
GGACU motif, where R = guanosine or adenosine and H = adenosine, cytosine, 
or uracil, (Harper et al., 1990; Wei and Moss, 1977b) and these results were 
corroborated by transcriptome-wide studies. (Dominissini et al., 2012; Meyer et 
al., 2012) The methyltransferases have been dubbed the “writers” and the 
demethylases the “erasers” of m6A. (Fu et al., 2014)  
Some of the potential “readers” of m6A, or the proteins that bind to the 
modification, have been identified to be the YTHDF1-3 proteins. (Dominissini et 
al., 2012; Wang et al., 2014a) In particular, YTHDF2 was found to bind to m6A 
sites and targeting them towards P-bodies for degradation. It is theorized that 
the other readers may have other purposes than RNA decay. It has been long 
known that m6A inhibits the activity of the ADAR enzyme to perform A-to-I 
(inosine) editing (Veliz et al., 2003), though current assays do not allow for 
specific validation of these sites and changes. While the exact function of m6A 
still remains unclear, it has been implicated in splicing and adipogenesis, (Zhao 
et al., 2014) regulation in embryonic stem cell development, (Wang et al., 
2014b) and the circadian rhythm (Fustin et al., 2013). Without fully knowing its 
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physiological purpose, its functional role can be elucidated by taking advantage 
of its dynamic nature: examining how it changes in response to cellular stimuli 
and stresses, between tissue and cell types, and across time.  
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CHAPTER 2 PROTOCOLS TO IDENTIFY METHYL-6-ADENOSINE 
2.1 Prior Publication and Rights to Reprint 
Portions of this chapter first appeared in (Saletore et al., 2012), including Figure 
2.4 and Figure 2.5. This manuscript is freely available at Genome Biology under 
the terms of the Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited. Full details regarding the Creative Commons 
License are available at http://creativecommons.org/licenses/by/2.0. 
2.2 Introduction 
Although an antibody was devised that was shown to preferentially bind to m6A 
in the 1970s, it was not publicly available until far more recently. (Munns et al., 
1977) Antibodies are often used in Western or immunoblots to show global 
levels of the epitope. Capitalizing on the wide-spread application of ChIP-
Seq, (Johnson et al., 2007) as well as similar methods in 5hmC detection before 
the advent of TAB-Seq, (Song et al., 2012) the antibody could also be used to 
selectively enrich for RNA fragments that contain m6A sites over those that do 
not. Combining this method with next generation sequencing (NGS), these 
fragments could be identified and mapped back to the genome, defining peaks, 
where putative m6A sites may exist.   
2.3 MeRIP-Seq: Methylated RNA Immunoprecipitation Sequencing 
Using western blots, Kate Meyer showed that the antibody bound selectively to 
m6A, (Meyer et al., 2012) demonstrating that the polyclonal antibody could be 
used in a pulldown-type assay. The initial method utilized Invitrogen RiboMinus 
beads to ribo-deplete RNA, to include RNAs that may not have been poly-
adenylated, zinc chloride chemical fragmentation of the purified RNA, and 
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utilized two-rounds of IP to achieve the highest possible enrichment while 
balancing sample loss. 
2.3.1 Ribosomal Contamination 
The high input amount of RNA required for MeRIP-Seq will be discussed in more 
detail in the next section (2.3.2 Input Requirements), but in most RNA-Seq 
studies, a rather large amount of RNA is required in general because upwards 
of 90-95% of the total RNA can be comprised of ribosomal RNA (rRNA). 
Although m6A is known to be found in some rRNA sites, most of the focus on its 
function is in messenger RNA (mRNA) and non-coding RNA (ncRNA), so 
successful removal of rRNA is crucial. Contamination by rRNA leads to 
significant loss of sequencing depth in genomic regions that are of interest. The 
two primary methods of rRNA removal utilize either polyA-pulldown or ribo-
depletion, the prior utilizing a string of deoxy-thymines to selectively bind to the 
poly-adenylated (polyA) tails on mRNAs to pull down and enrich for them, and 
the latter using cDNA complexes for rRNA sequences to bind to them and knock 
them down. The advantage of utilizing a ribo-depletion method is to enrich for 
RNA families that may be missed in a polyA pulldown, such as ncRNAs and 
long non-coding RNAs (lncRNAs) (Li et al., 2014b; SEQC MACQ-III 
Consortium, 2014; Yamamoto et al., 2014), but recent studies have shown that 
non-specific cDNA binding with the rRNA removal complexes can lead to 
sequencing bias (Lahens et al., 2014). 
The original MeRIP-Seq protocol requires upwards of 300 micrograms of total 
RNA as input, but utilizes RiboMinus™ Human/Mouse Transcriptome Isolation 
Kit (Life Technologies #K1550-01) to perform the ribo-depletion step. Per the 
manufacturer instructions, the beads can at most purify only 5 micrograms of 
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RNA in a single knockdown and cannot be re-used. Consequently, quality 
control measurements (shown in Figure 2.1) confirm the problem that utilizing 
such a high total RNA input with the RiboMinus beads results in not only a high 
degree of rRNA contamination in the sequencing sample, but also high variation 
of contamination between samples. While the sequencing loss in both money 
and sequencing depth is enormous, the further consequences of it on peak 
calling are discussed later in 3.4.5 Ribosomal RNA Contamination. This does 
demonstrate that for the standard high input protocol, RiboMinus and similar 
ribosomal knockdown methods are not suitable for full rRNA removal.  
One of the advantages of using polyA-pulldown enrichment is their high 
efficiency in rRNA removal, though at the loss of other RNA species, such as 
non-coding RNAs and long non-coding RNAs that are not polyA-tailed. 
However, it should be noted that fully intact and high quality RNA is also 
required, as mRNAs are pulled down by their polyA tails at their 3’ untranslated 
regions (3’ UTRs). Using degraded or low-quality RNA in a polyA-pulldown 
results in a 3’ UTR bias in the data and a loss of 5’ UTR coverage.  (Li et al., 
2014b) That being said, Dynabeads® Oligo(dT)25 (Life Technologies #61005) 
can not only be used to purify 75 micrograms of total RNA per reaction, but they 
can also be washed and re-used on the same sample again to purify up to a 
total of 300 micrograms of total RNA. Using these instead of the RiboMinus 
beads shows a dramatic improvement in rRNA removal, as shown in Figure 2.2. 
A parallel study in m6A mapping also successfully utilized the polyA-beads to 
achieve mRNA purification,  (Dominissini et al., 2012) though they unfortunately, 
and incorrectly, deemed the step as “optional” in their published methods 
protocol.  (Dominissini et al., 2013)  
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Figure 2.1: Poor Ribo-depletion in Meyer et al. (2012) Samples  
The distribution of RNA-sequencing data from Meyer et al (2012) samples, with 
percentage of reads mapping to intergenic regions in salmon, mitochondrial in 
dark yellow, intronic in green, exonic in teal, 5’ UTR in cyan, 3’ UTR in purple, 
and ribosomal in pink. The human and mouse samples from show a high degree 
of rRNA contamination, especially in the control samples, and a high variation 
of contamination between replicates. Reads that would normally be equally 
distributed across other gene features, such as the exons, are now consumed 
heavily by ribosomal regions.  
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Figure 2.2: RNA-Sequencing Distribution in Samples Utilizing PolyA Pulldown. 
The distribution of RNA-sequencing data from Heat Shock and Ribavirin 
samples (Chapter 5), with percentage of reads mapping to intergenic regions in 
salmon, mitochondrial in dark yellow, intronic in green, exonic in teal, 5’ UTR in 
cyan, 3’ UTR in purple, and ribosomal in pink.PolyA-pulldown RNA achieves a 
significant improvement in rRNA removal over RiboMinus with a high input 
amount of RNA.   
2.3.2 Input Requirements 
One of the main challenges to MeRIP-Seq is its high input requirement, in the 
hundreds of micrograms of total RNA. Methyl-6-adenosine was initially 
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estimated to be present on 0.1-0.4% of all adenosines,  (Dubin and Taylor, 
1975; Perry and Scherrer, 1975; Wei et al., 1975) so the amount of RNA being 
pulled down is very small in even a very successful IP, compounded by the 
removal of 90% of the total RNA in the rRNA removal step, as discussed 
previously. This puts MeRIP-Seq out of the range of most clinical samples and 
requires utilizing either whole organs or cell lines. The original protocol was also 
designed for two rounds of IP. Using qPCR, one round was estimated to achieve 
a 75-fold enrichment, and two-rounds a 130-fold enrichment, of m6A fragments 
over the background.  (Meyer et al., 2012) After the publication of the initial 
paper, the actual limitations of the protocol and its viability for clinical samples 
needed to be assessed. A titration experiment was performed by varying the 
input amount of RNA and attempting to perform both one and two rounds of IP 
until a point at which successful RNA-Seq libraries could not be built from the 
immunoprecipitated RNA.  
Table 2.1 shows the input amounts that were tested, though the fraction of 
fragmented polyA-purified RNA was estimated to be 1% of the total RNA input. 
More than 450 million Ly1 cells were collected by Tharu Fernando, PhD from 
the Ari Melnick, MD laboratory for the purposes of this test. The RNA was 
extracted, polyA-purified, and then fragmented to generate a consistent pool to 
not only measure what IP titrations were successful, but also its downstream 
consequences on sequencing and peak calling. The full titration experimental 
design would ultimately compare the impact of rounds of IP, input amount, and 
the library preparation method (Clontech vs Illumina). Table 2.1 also shows 
which IPs were successful and prepared into libraries with the Clontech and 
Illumina kits for sequencing. 
 
13 
 
Table 2.1: MeRIP-Seq RNA Input Titrations and Successful IPs 
RNA Input mRNA Antibody 1x IP 2x IP 
300 µg 3 µg 12 µg X X 
100 µg 1 µg 12 µg X X 
50 µg  500 ng 12 µg X X 
1 µg 10 ng 12 µg X X 
500 ng 5 ng 12 µg X  
250 ng 2.5 ng 12 µg X  
100 ng 1 ng 12 µg X  
 
The full experimental design prepared all samples using both Illumina and 
Clontech kits in two replicates each. In order to eliminate batch effects between 
preparation methods, samples from a single replicate were immunoprecipitated 
and pooled, before separating them again into their respective methods. For 
example, for a single replicate across the design, 4 total IPs were performed 
with the 100 µg input, pooled, and then separated into four aliquots, two for 1-
round IP preparation using Illumina and Clontech protocols, and the other two 
were immunoprecipitated for a second round, pooled, and then prepped using 
Illumina and Clontech. Figure 2.3 demonstrates how the RNA samples were 
separated, fragmented, immunoprecipitated, pooled, and prepped.  
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Figure 2.3: 100 µg Input Experimental Design to Minimize Batch Effects 
The experimental design for the 100 µg RNA input level shows how samples 
were extracted, pooled and split to minimize batch effects. The first pooling is to 
minimize batch effects between the IPs as well as to have a consistent RNA-
pool to input into the sequencing prep, and the second pooling is to again 
maintain the same pool of RNA inputted into Illumina and Clontech preparation 
methods. Replicates are denoted by color, green and orange, while Illumina 
prepped-samples are shown in white text on black and Clontech in black text 
on white background.  
Surprisingly, the 2-round IPs succeeded until about 50 µg input, and the 1-round 
IPs until 100 ng. However, later experiments revealed that this is likely because 
first, estimating the fragmented mRNA input as one percent of the total RNA 
was likely an overestimate and does not reflect the amount of RNA lost in each 
of the steps. Second, the experiment viability also depends highly on the 
efficiency of the IP achieved, which itself is a function of the antibody purity and 
function. As the antibody degrades, or if poorer antibodies are used, we 
continued to observe a drop in the success of IPs that had previously 
succeeded.  
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Although the Clontech kit did not provide as much of an advantage over the 
standard Illumina TruSeq kit, the experiment did provide insight into future 
experiments with the kit. Upon discussing the results with Clontech technical 
support, the first lesson was that the Clontech first-strand synthesis reverse 
transcription enzyme is hindered by glycogen, which unfortunately is used as a 
carrier in all of the ethanol precipitations. A potential solution is to perform the 
cleanups blind, without a carrier, but the possibility of sample loss is very high. 
The second challenge was that Clontech’s single-cell range kits are designed 
to utilize polyA-primed reverse transcription enzymes, which only work with fully 
intact total RNA. The input to the IP is fragmented RNA, and so random hex 
priming must be used, which unfortunately does not perform as well as polyA-
priming, per Clontech’s advice. The kit that was ultimately used was the 
SMARTer Universal Low Input RNA Kit (Clontech Catalog #634946), originally 
designed for degraded or formalin-fixed paraffin-embedded (FFPE) samples, 
which functions by using a random hex primer to generate cDNA complexes, 
and then utilizing additional PCR cycles, up to a total of potentially 30 cycles, to 
further amplify the library.  
Third, the Clontech manual recommended trimming up to seven nucleotides in 
silico post-sequencing, because some parts of the adapter sequences may 
remain, even after RsaI digestion. What was not mentioned was that these 
sequences may in fact impact sequencing color balancing, especially during the 
first five cycles, when the sequencers require full color balancing to accurately 
calibrate the bases. This resulted in a low number of reads passing the pass 
filter cutoff, and a very low sequencing throughput. A possible solution, 
developed for a similar problem observed in eRRBS (enhanced reduced 
bisulfide sequencing), is to perform dark cycle sequencing, where the bases are 
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sequenced as normal, but the camera is turned off. The camera can then be 
turned back on after the first seven base pairs have been skipped to finish the 
sequencing run. These subsequent bases would then have the necessary 
complexity for the sequencer to perform accurate base calibration. 
2.4 Direct RNA Sequencing 
The challenge with mapping m6A sites at single base-resolution is that current 
sequencing technologies, referred to as next-generation sequencing (NGS) or 
second-generation sequencing, are dependent on developing cDNA, or 
complementary DNA, libraries that are ultimately sequenced, after being 
polymerase chain reaction (PCR) amplified. RRBS (Meissner et al., 2005) takes 
advantage of bisulfide treatment to convert all non-methylated cytosines to 
uracil, which is sequenced as a thymine. Since methods to chemically convert 
m6A and many other RNA modifications remain unknown, the creation of the 
cDNA library ultimately results in the loss of all base modification information. 
One potential solution to achieve single nucleotide resolution is to directly 
sequence the RNA molecules. Third-generation sequencers was a term first 
used to generalize sequencing technology that directly sequences the DNA 
molecules directly, without utilizing any PCR amplification. Traditionally, these 
methods were designed for direct sequencing of DNA molecules, and RNA 
sequencing still relies heavily on cDNA library construction. However, research 
has shown that there still remains the potential to directly sequence RNA 
transcripts to identify base modifications.  
2.4.1 Pacific Biosciences RS 
In Pacific Biosciences of California, Inc.’s single-molecule real time (SMRT) 
technology, DNA polymerases are bound to the bottom of thousands of very 
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small wells, also known as zero-mode waveguides (ZMWs). A DNA strand is 
then fed to the polymerase and a camera records the replication of the strand 
in real time, as fluorescently tagged nucleotides are incorporated into the new 
strand. The fluorescent pulses can then be converted into base information, 
directly sequencing the original DNA strands. (Eid et al., 2009) Although the 
technology has been successful in achieving far longer reads than current 
Illumina and Ion Torrent technologies, the high error rate of up to 15% of each 
base has been a challenge and often requires high coverage to achieve a strong 
consensus sequence.  
In observing the incorporations of the nucleotides, PacBio further observed a 
consistent delay in the incorporation of some of the bases. They realized the 
inter-pulse distance (IPD), or the amount of time between each fluorescent 
observation, was dependent on the base modifications present on the original 
DNA strand. (Flusberg et al., 2010; Song et al., 2011) The activity of the DNA 
polymerase and its incorporation of nucleotides into the new strand is 
dependent on both the genetic and epigenetic markers. Although it requires 
even greater coverage than standard DNA-sequencing to call DNA 
modifications with high statistical confidence, the method first demonstrated that 
the technology could be used to discern unmodified bases from modified ones.  
The PacBio RNA-sequencing platform currently leverages the Iso-seq protocol, 
which creates long cDNA templates for sequencing. However, replacing the 
original DNA polymerase in the ZMW with a Human Immunodeficiency Virus 
(HIV) reverse transcriptase, native RNA transcripts can instead be fed and 
directly translated. Instead of performing cDNA synthesis prior to loading the 
templates onto the machine, the process of generating the cDNA template can 
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be observed. Comparing two synthetically prepared RNA oligonucleotides, one 
made with adenosines and the other with m6A, a similar kinetic signature can 
be observed as in DNA, as depicted in Figure 2.4 and the distribution shown in 
Figure 2.5. The study demonstrates the first direct-RNA sequencing method to 
identify RNA modifications at single nucleotide resolution. However, the figure 
also shows limitations of the method. The reverse transcriptase “stutters” during 
cDNA construction, which can be observed as multiple adenosine spikes for the 
sequencing of a single thymine base. This problem was in fact first observed in 
DNA sequencing on the PacBio platform, which was solved through 
adjustments to the DNA polymerase. Similar adjustments to the reverse 
transcriptase could yield more successful results.   
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Figure 2.4: Delay in Fluorescent Spikes in Presence of m6A 
Sequencing of synthetic RNA oligonucleotides on the PacBio RS, showing the 
time of base incorporation and fluorescence intensity in a.u. (normalized 
arbitrary units) as cDNA is generated by a reverse transcriptase. (a) Shows 
cDNA template construction of the normal oligonucleotide. (b) cDNA 
construction of the modified template, with m6As substituted for all adenosines 
in the template used in (a), showing a dramatic delay in the incorporation of 
thymines corresponding to m6A sites.  (Saletore et al., 2012) 
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Figure 2.5: m6A Sites Marked by Increased Inter-Pulse Distance (IPD) 
Box plot comparing the average inter-pulse distances for native adenosine (left) 
and m6A (right) shows a significant increase in the IPD in m6A.  (Saletore et al., 
2012) 
2.4.2 Oxford Nanopore Technologies 
Most current sequencing technologies take advantage of some form of 
replication with fluorescently tagged nucleotides, which are then used to 
reconstruct the original template. In contrast, instead of recording replication, 
sequencing methods to detect the DNA sequences using nanopores have been 
theorized and researched since the mid-1990s. (Kasianowicz et al., 1996) A 
DNA strand is guided through a nanopore with an electrical current passing 
through it, and changes in the current can be observed as different nucleotides 
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pass through the pore. Initial experiments showed that these current changes 
could be measured, but the resolution was low because the DNA moved through 
the nanopore too quickly to achieve single-nucleotide resolution. (Bayley, 2006) 
Oxford Nanopore Technologies licensed the usage of nanopore research from 
Harvard, UCSC to eventually develop the first commercialized nanopore 
sequencer. Theorized to use a custom alpha-hemolysin pore, changes in the 
electrical current as DNA molecules pass through the pore are recorded. 
Changes in current are recorded, which represent five-base k-mers of the 
template strand. Using a Hidden Markov-Model (HMM), these k-mers are then 
converted into bases. Although the average error in a single base can be as 
high as 30%, and its error model of increased insertions and deletions does not 
allow for successful alignment with most conventional aligners, the method does 
show promise in the ability to directly sequence the native DNA strand. DNA 
fragments are ligated with hairpin adapters that when pulled into the nanopore, 
can be used to pull the second strand through the pore. This method of 
sequencing, noted as 2D-sequencing, can be used to achieve higher base 
quality accuracy.  
Oxford Nanopore Technologies’ current focus has been on developing their 
DNA sequencing technology and improving base quality and throughput. 
However, some of their initial work has indicated that it may be possible to detect 
DNA modifications at single-nucleotide resolution using the same technology. 
As the DNA molecules pass through the pore, modified bases do appear to have 
their own electric signatures. Their current RNA sequencing protocol employs a 
cDNA library construction step, but previous iterations utilized only first-strand 
synthesis to generate a cDNA:RNA hybrid molecule that was then sequenced. 
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The hairpin adapters can be used to pull the RNA strand through, resulting in 
direct RNA sequencing, similar to what was achieved earlier on the PacBio 
platform. In particular, this has to potential to detect RNA modifications at single-
nucleotide resolution.   
2.5 Conclusions and Future Work 
Until a chemically-based method, such as using bisulfide treatment to find 5mC, 
can be formulated to differentiate m6A sites from adenosine, MeRIP-Seq serves 
as the best method for full transcriptome-wide mapping of m6A sites. The 
method is dependent on the successful pulldown of RNA fragments using an 
antibody, introducing high variance and variability into the protocol. The original 
high input limit was required to ensure successful two-rounds of IP, but for 
experimental designs with limited RNA input, a single-round can be used to 
enable IPs at lower inputs. For ultra-low input experiments, below the one 
microgram range, a method similar to the iChIP protocol could be 
adapted. (Seumois et al., 2014) Instead of ligating DNA adapters, RNA adapters 
could be ligated to the RNA fragments, enabling pooling of samples. (Shishkin 
et al., 2015) While a single sample may not have enough RNA for a successful 
IP, pooling multiple samples could enable IPs at even lower ranges. Carrier 
RNA from a cell line could be further used to ensure that the IP is successful.  
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CHAPTER 3 MERIPPER: MERIP-SEQ PEAK FINDER 
 
3.1 Prior Publication and Rights to Reprint 
Portions of this chapter first appeared in (Saletore et al., 2012). This manuscript 
is freely available at Genome Biology under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited. Full 
details regarding the Creative Commons License are available at 
http://creativecommons.org/licenses/by/2.0.  
3.2 Introduction 
The MeRIP-Seq protocol comprises the wet laboratory/bench half of identifying 
m6A sites, pulling down RNA fragments with m6A sites and sequencing them. 
As is the case in ChIP-seq, the computational half is aligning these fragments 
and converting them into putative m6A site locations, or peaks. These peaks 
can then be annotated with known gene locations and used to elucidate the 
possible functional role of m6A. 
3.2.1 Previous Peak Calling Methods 
Since the advent of ChIP-seq protocols, multiple peak finders have been 
created that use a multitude of methods and statistical tests to attempt to identify 
peaks. Many of these were specifically designed for ChIP-seq analysis but may 
still be used to find IP-rich regions in RNA-seq data. Some of them can take as 
input a control sample, which in theory could be used to some extent to 
normalize by RNA transcript levels. MACS (Zhang et al., 2008) has become the 
most commonly-used peak finder in ChIP-seq analysis and was also used to 
identify peaks in multiple m6A studies, (Dominissini et al., 2013; Dominissini et 
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al., 2012) while ChIPseeqer (Giannopoulou and Elemento, 2011) provides a full 
suite of annotation and motif finding tools in addition to its peak finder.  
MeRIPPeR (Meyer et al., 2012; Saletore et al., 2012) was the first m6A-specific 
peak finder, designed to use heuristics specific to MeRIP-Seq data. Although its 
methods were made public, as a stand-alone tool it had not been published and 
another group adapted a Perl implementation that used the same methods. (Li 
et al., 2013) Following this, the peak finder exomePeak, (Meng et al., 2013; 
Meng et al., 2014) which analyzes peaks only within exonic regions, was 
published as a “FRIP-Seq” (Meng et al., 2013) peak analysis tool, to analyze all 
fragmented RNA IP sequence data. The software is packaged as a 
Bioconductor (Gentleman et al., 2004) package, processes windows spanning 
across connected exons from an inputted annotation, and uses the Poisson 
distribution to model the read count data.  
3.3 Methods 
3.3.1 Alignment 
The first step in the analysis of any sequencing data is the accurate alignment 
of the short-reads to a reference genome. In Meyer et al. (2012) the burrows-
wheeler genomic DNA aligner BWA (Li and Durbin, 2009) was used and the 
Dominissini et al study (Dominissini et al., 2012) used the equivalent BowTie 
aligner (Langmead et al., 2009). At the time, gap and splicing-aware aligners, 
such as TopHat (Trapnell et al., 2009) and GSNAP (Wu and Nacu, 2010), were 
still in their infancy, and STAR (Dobin et al., 2013) had not been published. The 
choice of aligner can have a significant impact on the number of peaks called 
and the accurate annotation of those peaks.  (Saletore et al., 2012) Figure 3.1 
shows the fraction of reads successfully mapped and Figure 3.2 shows the 
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distribution of the mapped reads to gene features, both comparing the choice of 
aligner and the usage of a gene annotation.  
 
Figure 3.1: Gapped RNA-Seq Aligners Map More Reads than BWA 
Fraction of the reads mapped is shown for each of the Meyer et al. (2012) 
human samples, with BWA shown in peach, STAR in lime-green, GSNAP in 
cyan, and TopHat in purple. BWA aligns the fewest reads, likely due to its 
inability to map spliced reads. TopHat aligns more reads compared to the other 
aligners without an annotation set or using RefSeq annotation, so these aligned 
reads may potentially represent falsely spliced reads, as fewer reads are 
mapped using TopHat with Ensembl annotations.  
BWA, BowTie, and other genome aligners were specifically designed to align 
DNA-sequencing data to the reference genome. RNA transcripts in Eukaryotic 
organisms are assembled from splicing together exons from immature pre-
mRNA transcripts and removing intronic segments. (Will and Luhrmann, 2011) 
This process occurs in spliceosomes in nuclear speckles found in the 
nucleus, (Lamond and Spector, 2003) incidentally where FTO was found to co-
localize, implicating m6A in this process. (Jia et al., 2011) Splicing complicates 
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the alignment of reads to a reference genome, specifically reads coming from 
RNA fragments that span across a splice junction. 
 
Figure 3.2: TopHat Aligns More Reads to Intergenic Regions without Annotation 
The distribution of reads mapped by different aligners (x-axis) to gene features 
by percent (y-axis), with intergenic in salmon, mitochondrial in dark yellow, 
intronic in green, exonic in teal, 5’ UTR in cyan, 3’ UTR in purple, and ribosomal 
in pink. The distributions look mostly comparable between different aligners. 
TopHat tends to align more reads to intergenic regions without a reference 
annotation, which could be caused by mis-aligned reads.  
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Genomic aligners were not designed to handle spliced data, resulting in lack of 
coverage near splice-junctions, as shown in Figure 3.3, corroborating the fewer 
reads mapped by BWA in Figure 3.1. DNA-aligners can be used to align RNA-
seq data to a reference transcriptome, fixing analysis to an annotation.  
 
Figure 3.3: BWA Shows Lack of Coverage at Exon Ends 
Heat map of percentage of reads mapping to each exon binned into 100 bins 
on the x-axis, with aligner shown on y-axis, and choice of annotation varying 
horizontally for the three control samples from Meyer et al. (2012).The splice-
aware aligners map reads more uniformly across exons, while BWA has clear 
drops at the 5’ and 3’ edges of exons. 
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Gapped aligners, such as TopHat, GSNAP, and STAR, are specifically 
designed to map RNA-sequencing data to a reference genome. TopHat works 
by attempting to align reads using BowTie and then handling those reads that 
do not map well separately. (Trapnell et al., 2009) STAR aligns maximal 
mappable prefixes during the seeding phase, and then extending these prefixes 
to detect splice junctions and mismatches. (Dobin et al., 2013) GSNAP uses k-
mers, such as oligomers of 8-mers, to perform a similar alignment. (Wu and 
Nacu, 2010). STAR is often favored over GSNAP and TopHat, for both its speed 
and for TopHat’s high false positive rate (Figure 3.1 and Figure 3.2). (Li et al., 
2014a; Li et al., 2014b; SEQC MACQ-III Consortium, 2014) Accurate alignment 
of the reads directly affects the ability to call peaks, especially peaks near splice 
junctions.  (Saletore et al., 2012)   
Venn diagrams showing the impact of both choice of aligner, Figure 3.4, as well 
as the impact of using an annotation database on STAR, GSNAP, and TopHat 
in Figure 3.5, Figure 3.6, and Figure 3.7, respectively. STAR performs the best, 
with a good balance of speed and accurate alignment, while TopHat has 
artifacts present both in the distribution of mapped reads and peaks called in 
the absence of an annotation database. GSNAP has the best agreement with 
or without using an annotation database, and calls mostly the same peaks as 
STAR.  
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Figure 3.4: Most Bases Common to all Peak Callers 
The number of bases called by each of the peak callers in their respective peaks 
and bases common to overlapping peaks is shown. The different aligners call 
essentially the same peak regions, with the majority of bases in the intersection 
of all of them. Depicted is count of the number of base pairs common to each 
region. BWA misses peaks near exon ends, while STAR has the best balance 
of speed and accuracy. TopHat has an unusually high number of peaks unique 
to itself, likely the result of incorrect read alignments. (Li et al., 2014a; Li et al., 
2014b; SEQC MACQ-III Consortium, 2014) 
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Figure 3.5: Nominal Changes to STAR Peaks by Choice of Annotation 
Number of bases overlapping in peaks called by STAR using different 
annotations. STAR calls the same peaks for the most part, regardless of the 
annotation database used, only a few kilobases of peaks are unique to using an 
annotation database, which could aid in the alignment of spliced reads.  
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Figure 3.6: Very Small Changes in GSNAP Peaks Caused by Choice in 
Annotation 
Number of bases overlapping in peaks called by GSNAP using different 
annotations. GSNAP has the best agreement between its aligner and usage of 
an annotation database. Despite using RefSeq or Ensembl annotations, the 
majority of the peaks are still called the same.  
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Figure 3.7: High Variation in TopHat Peaks Caused by Choice of Annotation 
Number of bases overlapping in peaks called by TopHat using different 
annotations. TopHat shows the greatest variance with annotation databases. 
An empirical run of TopHat likely misaligns many reads, while the Ensembl 
alignment provided the best expected distribution of read counts earlier.  
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3.3.2 Fragment Shifting and Extension 
In standard ChIP-seq protocols, DNA is fragmented to 200-300 base pairs using 
sonication,  (Barski et al., 2007) but typically only the first 36-50 base pairs may 
actually be sequenced. This will result in two observed peaks, often on opposite 
strands, spanning a single chromatin binding site. The actual binding site can 
be found by calculating the fragment shift from paired-end sequencing data or 
estimating it from single-end sequencing data and shifting each read towards 
the 3’ end accordingly, as used in MACS. (Zhang et al., 2008) The same can 
be said for RNA sequencing on the Illumina platform, where RNA samples are 
chemically fragmented to approximately 100 base pairs and usually sequenced 
single-ended 50 base pairs. Paired-end sequencing and longer reads may be 
used to achieve greater sequencing depth and additional splicing and isoform 
usage. (Li et al., 2014b) Newer Illumina strand-specific kits will result in reads 
on the 5’ end of each RNA fragment. 
MACS and exomePeak both use fragment shifting as a means of correcting the 
5’ library bias. (Meng et al., 2013; Zhang et al., 2008) In the context of DNA-
sequencing and ChIP-seq peak calling, fragment shifting is a good solution to 
the 5’ shift problem. The MACS method models this shift in single-ended data 
by plotting the Watson and Crick strands (positive and negative) independently 
and calculating the shift. However, using this method in RNA-Seq data is far 
less straightforward. First, the results from using MACS on the MeRIP-seq data 
from (Meyer et al., 2012) are shown in Figure 3.8.  
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Figure 3.8: Fragment Shifts Computed using MACS2 
The fragment shifts were computed for the original Meyer et al. (2012) data 
using MACS2 (Zhang et al., 2008), with the human samples on the left and the 
mouse samples on the right, and the three replicates by row. The red lines 
indicate the inferred fragment distance between the tags outputted by MACS2, 
and the blue indicates reads mapping to positive/Watson strand, the green to 
the negative/Crick strand.  
Following standard MeRIP-Seq and Illumina sequencing preparation protocols, 
the fragment distributions should have been around 100 base pairs with only 50 
base pairs sequenced on the ends, with the exception of the mouse sample 
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replicate 1 that had only 36 base pairs sequenced. The calculated shifts from 
MACS are inconsistent with the protocol and very greatly between replicates. 
This is likely because unlike ChIP-seq, which targets chromatin and 
transcription factors, m6A and other RNA modifications are at single-base 
points. Multiple m6A sites next to each other can confound this analysis and 
make it more challenging to correctly calculate this shift. 
The software in exomePeak instead opts to use a user-supplied parameter to 
model this shift. Inputting a mean fragment length of 100 base pairs, the 
software shifts all reads half of that, or 50 base pairs, towards the 5’ end. This 
circumvents the modeling challenges in MACS, but fragment shifting has its own 
problems in RNA-Seq. In the absence of large structural variation, shifting and 
extending DNA sequencing data is fairly trivial. In contrast, RNA-sequencing 
data from eukaryotes comes from a spliced transcriptome. Naively shifting 
reads in genomic space ignores read splicing and would result in shifting exonic 
reads into intronic spaces. exomePeak avoids this by shifting reads in the 
transcriptome space, but this then assumes that a particular read came from a 
specific annotated gene. The read could have come from a transcript that was 
alternatively spliced, contained a retained intron, or even from an immature 
transcript that had not yet been spliced. Making assumptions about the 
underlying data around these edge cases can lead to artifacts, as shown in 
Figure 3.9. Here, exomePeak incorrectly calls peaks in SLC9A3, a gene that is 
otherwise not expressed. By shifting the reads 50 base pairs to the 3’ end, the 
algorithm shifts reads from BC013821, a gene that is on the opposite strand and 
part of which overlaps with an exon from SLC9A3, and incorrectly calls peaks 
in exons of SLC9A3.  
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Figure 3.9: exomePeak Fragment Shifting Artifact 
In black are exomePeak peaks depicted separately by strand and UCSC genes 
depicted in grey which were used to call the peaks in transcriptome space. 
Coverage from the RNA-seq replicates are shown, alternating MeRIP-seq and 
control-seq samples. exomePeak incorrectly calls peaks in SLC9A3 which is 
not expressed. Plotted using The Integrated Genome Browser (IGB). (Nicol et 
al., 2009) 
Another potential solution to the 5’ shift is fragment extension; extending each 
mapped read towards its 3’ end until it is the average fragment length (100 base 
pairs), as used in ChIPseeqer’s peak finder. (Giannopoulou and Elemento, 
2011) Unfortunately, the same edges cases in fragment shifting are also present 
in extension in RNA sequencing data. The only advantage it has over fragment 
shifting is that many reads may in fact map over the m6A site, which could lie 
anywhere along the 100 base pair fragment. Although MeRIP-seq data does 
show some 5’ bias, there does not appear to be a clean solution to solve 
problem. Without paired-end sequencing data to confirm the exact length, 
splicing, and location of each fragment, the best solution is to simply not adjust 
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for it to avoid making assumptions about the underlying data and introducing 
artifacts.  
3.3.3 Testing for IP Enrichment 
After aligning to the genome, the next step is to test for statistically significant 
enrichment in the IP sample. MeRIP-Seq uses an antibody-based enrichment 
and antibodies are known to have non-specific binding, as well as the potential 
for other RNA fragments to be pulled down, resulting in background noise that 
can impede peak calling. MACS and exomePeak model enrichment using the 
Poisson distribution and edgeR uses the negative binomial distribution to model 
RNA-sequencing count data.  (Meng et al., 2013; Robinson et al., 2010; Zhang 
et al., 2008)  
The MeRIPPeR peak finding protocol uses Fisher’s Exact Test, ensuring that 
the test only tests for significance in the direction of the IP. The original method 
utilized 25 base pair book-ended windows that spanned across genome, but 
this methodology can be expanded to include overlapping windows of a user-
specified size. The Fisher’s table used to calculate the p-value is shown in Table 
3.1, which compares the enrichment in the current window to the enrichment 
observed outside of the window. Fisher’s exact test is a non-parametric test that 
makes no assumptions of the distribution of the underlying data, and this 
particular table serves to normalize for differences in sequencing depth that may 
be present between the MeRIP and control samples. Fisher’s exact test will 
return a p-value, which is then adjusted using Benjamini-Hochberg to account 
for the multiple testing problem.  
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Table 3.1: Fisher’s Exact Table used to compute Fisher’s Test 
 # Reads in Window # Reads Outside Window 
MeRIP [MeRIP Reads in Window] [Total MeRIP Reads Mapped]  
- [MeRIP Reads in Window] 
Control [Control Reads in Window] [Total Control Reads Mapped]  
- [Control Reads in Window] 
 
3.4 Challenges in Peak Finding 
Although the MeRIP-Seq protocol is fairly standard, many inconsistencies in the 
implementation of the protocol can introduces biases that complicate peak 
finding. Unlike eRRBS, which is chemically based, IP-based enrichment 
methods are highly sensitive to the antibody and its efficiency. In addition, the 
method of RNA isolation and choice of aligner all can have an impact on the 
ability to call peaks. Some of these challenges can be solved, while others, 
unfortunately, cannot be accounted for, but their effect on peak calling must 
nonetheless still be considered.   
3.4.1 Antibody Non-Specific Binding 
An antibody is a Y-shaped immunoglobulin (Ig) protein, traditionally produced 
by the immune system to identify bacteria, viruses, and other foreign agents. 
Most of the antibodies produced for MeRIP-Seq are created by injecting rabbits 
or mice with free m6A in bovine serum albumin (BSA). The host produces 
antibodies in response to the m6A and develops specific antibodies that bind to 
the m6A antigen. These antibodies are then extracted and purified for use in 
immunoblots and IPs. Most of the antibodies used in MeRIP-Seq are polyclonal, 
meaning they are derived from different B cell lineages. Some monoclonal 
antibodies exist (Synaptic Systems #202 011 and #202 111 and others), but 
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their efficacy has not yet been tested in the IP. The purpose of the purification 
process is to isolate those antibodies that bind specifically to m6A. The binding 
of the antibody to the target of interest is dependent on the specificity of the 
antibody to the epitope on the antigen. In the case of m6A, the antibody must be 
able to distinguish between m6A, adenosine, and other nucleotides. Regardless, 
non-specific binding, where the antibody binds to something other than the 
antigen, can still occur. Monoclonal antibodies have the advantage of higher 
specificity to the epitope, and in theory, should result in lower non-specific 
binding. 
In addition, in the MeRIP-Seq protocol utilizes Dynabeads® M-280 Sheep anti-
Rabbit IgG to pulldown the antibodies. The beads are first washed with BSA to 
reduce non-specific binding in IgG of the beads. The m6A antibody and beads 
are then bound and washed to remove any antibodies that may not have bound. 
The RNA is then bound to the m6A antibody and unbound RNA is washed. The 
immunoprecipitated RNA is ultimately extracted by using a magnet to separate 
the superparamagnetic beads bound to the sheep anti-rabbit IgG, which is 
bound to the m6A sheep antibody, which itself is bound to the RNA. These 
multiple binding steps can not only affect the sensitivity of binding, but also 
introduce RNA fragments that do not contain m6A sites. The m6A-seq protocol 
utilizes Protein A instead of the Dynabeads, which can also introduce non-
specific binding of its own, and thus the protocol recommends using a beads-
only control to measure the level of background binding. (Dominissini et al., 
2013)  
IP-enrichment methods rely on both the successful pulldown of RNA fragments 
that contain m6A sites, as well as the removal (through washing) of RNA 
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fragments that do not. The (Meyer et al., 2012) paper showed using real-time 
polymerase chain reaction (RT-PCR) that a single round of IP achieved 70-fold 
enrichment of m6A fragments over background binding and two-rounds 
achieved 130-fold enrichment. These results represent the enrichment at the 
fragment level, but after library preparation, the sequencing results are likely 
more varied and dependent on each transcript and far more features. 
Unfortunately, without good negative controls or the ability to verify the lack of 
m6A sites, the exact amount of non-specific binding is difficult to measure.  
Spike-in RNA-sequences have often been used to assess quality control 
metrics of RNA-sequencing data. (SEQC MACQ-III Consortium, 2014) RNA 
oligonucleotides that are designed to not map to any known sequences, these 
sequences can be “spiked-in,” hence the name, to measure library preparation 
and sequencing biases. For the purposes of MeRIP-seq, four such sequences 
were constructed using in-vitro transcription (IVT) based on DNA 
oligonucleotides of lengths 71-100. The oligonucleotides were specifically 
designed with only a single thymine site, resulting in the creation of a single 
adenosine in the corresponding RNA transcript. This enables running two 
simultaneous IVT reactions, one that utilizes only adenosine in its mix of 
nucleoside triphosphates (NTPs) and another that contains only m6A. The two 
reactions can then be normalized and mixed at specific ratios, yielding spike-
ins that have varying percentages of m6A. These spike-ins were synthesized by 
Kate Meyer, PhD and sequenced as part of an exploratory m6A project. The log 
2 peak enrichment and the corresponding percentages of m6A used are shown 
in Figure 3.10. Peaks were not called on the 0% spike-in, which did not pass 
Fisher’s exact test in all replicates, but some replicates still show a high degree 
of non-specific binding. Nonetheless, the somewhat linear trend in the increase 
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in observed log 2 peak enrichment does show promise in the ability to 
recapitulate m6A levels with the IP.  
 
Figure 3.10: Linear Distribution of Spike-In RNAs Correlates with Methylation 
Fraction 
The distribution of log2 peak enrichments of four spike-ins used in an experiment 
are shown, with the percentage of methylation on the x-axis and the distribution 
of log2 peak enrichment on the y-axis. The percentage of m6A present compared 
to the enrichment shows a high degree of variability in the IP.  
3.4.2 MeRIP-Seq IP Enrichment 
In the previous section, the properties of the antibody and its effect on specific 
and non-specific binding was discussed. In the  (Meyer et al., 2012) paper, the 
IP enrichment was defined as the fold-enrichment of m6A containing fragments 
over non-specific binding. Ideally, the enrichment of a single peak is a function 
of this enrichment, the expression level of that transcript, and the percentage of 
transcripts that contain m6A in the peak region. Unfortunately, the IP enrichment 
itself is a function of multiple factors, including the amount of RNA used in the 
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IP, and is potentially variable with respect to each RNA fragment and influenced 
during PCR by GC-content biases and the mappability of the transcript by the 
aligner. (Li et al., 2014a; Li et al., 2014b; SEQC MACQ-III Consortium, 2014) 
The input titration experiment and multiple rounds of IP initially used to 
determine the input levels of MeRIP-seq, discussed earlier in section 2.3.2 Input 
Requirements, can be used to elucidate the variability of IP enrichment across 
replicates, and the sequencing impact of utilizing two-versus-one round of IP. 
Using the default MeRIPPeR peak caller, the number of bases in peaks called 
is shown in Figure 3.11. Unfortunately, some of the replicates did not perform 
as well as expected, such as the first replicate of the single-round 300 
microgram IP and the second replicate of the two-round 100 microgram IP.  
 
Figure 3.11: Increased Number of Peak Bases in 2-Round IPs 
The number of bases in peaks is shown, with one-round IPs shown on the left, 
two-round IPs on the right, and the input in micrograms on the x-axis. Some of 
the replicates did not perform as well, and are likely a technical failure in the IP 
and not specific to the input amount. 
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Plotting the number of bases spanned by peaks, versus total number of peaks, 
is a more fair representation of the genomic span of the peaks. Using solely the 
number of peaks, for example, does not show the size of each peak. Using two-
rounds of IP results in more peak bases being called, as expected, with reduced 
background noise from non-specific binding. Plotting the distribution of peak 
enrichments using sliding windows of size 100 and step-size 25 across the 
union of all peaks in Figure 3.12 confirms a strong lack of enrichment in those 
replicates, as well as strong disparities in the distribution of peak enrichments 
in the one-round 300 microgram IP. Although the first replicate appears to be a 
cleaner IP, the fewer number of peak bases called in Figure 3.11 demonstrate 
that the first replicate had poorer IP efficiency or higher specificity. The failed 
replicates are likely technical artifacts from failed IPs and will be excluded as 
outliers.  
Removing the peaks from the failed replicates and recalculating the log 2 peak 
window enrichments using the same sliding window method in Figure 3.12 
shows a clear increase in the average peak enrichment in the two-round IPs 
over the one-round IPs, as expected, shown below in Figure 3.13. It should be 
noted that in each IP, there are clear windows with log 2 peak enrichments 
below zero, which are from peaks not called in that particular replicate but in 
other replicates, and represents technical variation in the IP, because the initial 
RNA pool used for this experiment was the same. With both replicates 
successful in the one-round and two-round 50 microgram experiments, the 
increase in IP efficiency can be computed by comparing the mean enrichments 
observed. Using 100 base pair sliding windows at a step size of 25 base pairs 
across the intersection and union of each set of peaks, the one-round and two-
round IPs separately, the enrichment scores are plotted in Figure 3.14.  
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Figure 3.12: Density of Peak Enrichment Windows in IP Input Test 
Density plot of log2 peak enrichment, with one-round IPs shown on left and two-
round on the right, input in micrograms varying vertically, and replicates by color. 
The density distributions confirm lack of enrichments in technical replicates, 
showing far less enrichment in the first replicate of the 100 microgram one-round 
IP and the second replicate of the two-round 100 microgram IP. The 300 
microgram one-round IP replicates show a strong disparity in their enrichment 
densities.   
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Figure 3.13: Increased Mean Peak Enrichment in 2-Round IPs 
Violin plot of the peak enrichment from Figure 3.12 with one-round IPs on the 
left, two-round IPs on the right, input in micrograms on x-axis, and replicates by 
shading, shows an increase in enrichment of two rounds of IP over one.  
 
Figure 3.14: Linear Correlation of Technical Replicates in IP 
Log2 peak enrichment scores with replicate 1 on x-axis and replicate 2 on y-
axis, windows from the union of peaks in black and intersection in red, and linear 
fit shown in blue, one-round IPs shown on left and two-round on right. The 
enrichment scores show a strong correlation between replicates. 
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The details of fitting the linear model to the CPMs are summarized in Table 3.2. 
The linear fit R2 values for the single-round and double-round IPs are 0.8911 
and 0.8690, respectively. The linear model was fit to the windows from the 
intersection of the peak replicates. A linear model fit to the windows from the 
union of the peak replicates resulted in a fit skewed from observable trend and 
the intersection fit. The union fit was skewed by windows with very low to near 
zero read counts in one of the replicates and very low read counts in the other. 
This is consistent with previous findings in RNA-seq of being able to make more 
confident estimations of RNA transcript abundances of genes that are highly 
expressed over those that are not. (Anders and Huber, 2010) The Pearson 
correlations of the union window CPMs are 0.5642 and 0.7628, respectively, 
which is well below previously reported correlations for technical replicates of 
RNA-seq data,  (Yamamoto et al., 2014). The same Pearson correlations of the 
intersection window CPMs are 0.9440 and 0.9322, which shows a very strong 
correlation of peak enrichments in peaks common to technical replicates.  
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Table 3.2 Summary of 50 Microgram IP Linear Modeling in Replicates 
 1-Round IP 2-Round IP 
Linear Modeling 
Intercept 0.1366 0.1034
Slope 0.9692 0.9830
R2 0.8911 0.8690
P-value < 2.2e-16 < 2.2e-16
Union Window Correlations 
Pearson Correlation 0.5642 0.7628
Variance 1.4879 0.8913
Intersection Window Correlations 
Pearson Correlation 0.9440 0.9322
Variance 1.6475 0.8057
 
3.4.3 The Advantages of Two Rounds of IP  
The two-round IP is implemented by first performing a single round of IP and 
then inputting that RNA back into a second round of IP. The experimental design 
was constructed such that the two-round IP replicates would be matched to the 
one-round IP replicates, in that their input was the same pool of RNA that was 
sequenced as the one-round IP, as discussed earlier in Figure 2.3. The results 
of comparing the two-round IPs to the one-round IPs using their enrichment 
scores are depicted below in Figure 3.15. There’s a clear subset of peaks that 
are present in the one-round and not in the two-round IP, and vice versa. 
However, the results from the Figure 3.12 and Figure 3.13 earlier do show that 
the two-round IPs achieve better IP enrichment and better technical replication, 
with lower observed variance in peak enrichment.  
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Figure 3.15: High Variability in Peak Enrichment Between 1- and 2-Round IPs 
The log2 peak enrichment for windows shown for 1-round IPs on x-axis, 2-round 
on y-axis, with the first replicate on left and second replicate on the right, 
windows from union of peaks in black and intersection of peaks in red. A large 
number of peaks are found unique to each set of IPs.  
3.4.4 Determining and Correcting Batch Effects 
Multiple batch effects were discussed, including the input amount of RNA, the 
IP efficiency, and the usage of one versus two rounds of IP.  The IP efficiency 
is itself likely dependent on the input amount of RNA and other factors. Using 
principal component analysis on the peak enrichment scores, the dominant 
feature is the rounds of IP, shown in Figure 3.16. The second dimension could 
correspond to the IP input, if ignoring the replicates that showed poorer IP 
efficiency. Figure 3.17 shows a scree plot, or the variance, in the PCA analysis, 
demonstrating that the first two components capture the majority of the 
variance.  
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Figure 3.16: Greatest Separation in IP Input Test Corresponds to Rounds IP 
A principal component analysis (PCA) of the IP Input Test IP enrichments shows 
the first dimension corresponding to the rounds of IP. IP replicates with low 
technical variability cluster well together. Samples are colored by input and 
rounds of IP.  
 
Figure 3.17: First Two Dimensions Capture Majority of Variance in IP Input Test 
PCA Analysis 
A scree plot showing the variance of the principal component analysis of the IP 
input test peak enrichment scores.  
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In computing the peak enrichments, the raw counts are converted to counts per 
million, normalizing by the number of mapped reads to account for differences 
in sequencing depth. The trimmed-mean method (TMM) (Robinson and 
Oshlack, 2010) from edgeR (Robinson et al., 2010) is typically used to adjust 
for the number of genes in the sample, used to scale the effective library size. 
This scaling factor can be applied to the MeRIP-Seq samples to account for the 
amount of m6A, and the non-specifically bound fragments, present in each of 
the replicates. Figure 3.18 shows the TMM scaling factors for the MeRIP-seq 
samples, which shows the two-round IPs have often double the scaling factor 
of the single-round IPs. A larger scaling factor, applied in the denominator, 
would result in further shrinkage of the counts, accounting for the increased 
enrichment observed. This scaling factor can be used to effectively account for 
various batch effects, especially the number of rounds of IP in the sample. PCA 
analysis of the scaled enrichments, shown in Figure 3.19, does not show as 
clear separation on the first or second axes corresponding to the rounds of IP.  
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Figure 3.18: Double TMM-Scaling Factors in 2-Round vs 1-Round IPs 
The TMM scaling factors from edgeR computed only on the MeRIP-Seq 
samples (y-axis), with input in micrograms and replicate on x-axis and rounds 
of IP separated with one-round on left and two-round on right. The two-round 
IPs shows a clear increase, approximately double, in the scaling factor applied, 
relative to the single-round, with the exception of the failed replicate.  
 
Figure 3.19: TMM-Adjusted PCA Shows Better Clustering of Samples 
Applying the TMM scaling factors to compute the counts per million (CPM) prior 
to calculating normalizes for various batch effects, including rounds of IP. 
Samples are colored by input and rounds of IP. 
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3.4.5 Ribosomal RNA Contamination 
Earlier, the sequencing consequences of rRNA contamination was discussed. 
During peak analysis, rRNA sequences can also have a profound impact on the 
peak calling. In the trimmed-mean method (TMM) (Robinson and Oshlack, 
2010) paper, the abstract example the authors depicted described two sample 
sets, samples A and B, which had been sequenced with the same number of 
reads each. Sample A has twice as many genes expressed as Sample B, and 
the coverage of each gene in A is therefore half as that in B. Traditional library 
depth normalization methods use the total number of mapped reads, which in 
this case is the same for both samples, and the majority of genes between the 
two samples would incorrectly be calculated as differentially expressed.  
The rRNA contamination in MeRIP-Seq can be viewed similarly as an unknown 
set of genes that consume sequencing reads. Without properly normalizing for 
this contamination, the coverage in each genomic window is computed to be far 
lower than it actually is. Furthermore, since the amount of rRNA contamination 
is far greater in the control RNA-Seq samples than the MeRIP samples, the 
effect is observed to a much higher degree in the control samples. The end 
result is that the coverage is estimated to be lower in the control than it should 
be, relative to the IP, and more peaks are called, artificially and inadvertently 
increasing the false discovery rate (FDR). Insufficient rRNA depletion can occur 
for a variety of reasons, from poor ribosomal depletion (Meyer et al., 2012) to 
skipping the step in its entirety (Dominissini et al., 2012). 
In the event that rRNAs were poorly depleted, one potential solution is to 
computationally remove the contaminating reads. That is, the reads can be first 
aligned to known ribosomal sequences, and only those reads that do not align 
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are kept for subsequent analysis. In contrast to Figure 2.1, Figure 3.20 shows 
the dramatic reduction in rRNA contamination after in silico removal.  
 
Figure 3.20 Successful In Silico Removal of rRNA Contamination in Meyer et 
al. (2012) samples.  
Percentage of reads mapping to gene features shown on y-axis, with sample 
type and replicate on x-axis. Gene features are colored, with intergenic in 
salmon, mitochondrial in dark yellow, intronic in green, exonic in teal, 5’ UTR in 
cyan, 3’ UTR in purple, and ribosomal in pink. Aligning the reads first to a 
ribosomal RNA reference and then aligning only those reads that did not map 
to rRNA regions results in a highly successful removal of rRNA contamination.   
54 
The caveat here is that when the original sample already has low sequencing 
coverage, filtering out reads can result in very few mapped reads remaining, 
which may not provide enough coverage to call peaks, as shown in Figure 3.21. 
 
Figure 3.21 Loss in Total Number of Reads Mapped Following rRNA Removal 
The number of reads mapped (y-axis) before (salmon) and after (cyan) in silico 
filtering, with control samples on left, IP samples on right, human samples on 
top, mouse samples on bottom, and replicate varying across x-axis. In silico 
removal of rRNA reads when a high degree of rRNA contamination is present 
results in a dramatic reduction in the total number of reads mapped post-
filtering.  
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3.4.6 Splice Junctions 
Splice junctions in the transcriptome present a challenge both in the alignment, 
as well as in peak calling. The advantage of exomePeak is that it can call peaks 
that may span across a splice junction by choosing to operate in the 
transcriptome space. This comes at the cost of being restricted to an annotated 
set of exons and prevents analysis of intronic and novel unannotated regions. 
MeRIPPeR’s original genome-based window method successfully identified 
peaks within exons, but windows that span an exon-intron boundary may lose 
sensitivity due to mapping issues. For example, in Figure 3.22, the default 
MeRIPPeR genomic-based windows falls short at the end of the exon, likely 
because the next 5’ window falls mostly in intronic space with far fewer reads.  
One solution is to augment the traditional genomic based-windows with 
windows spliced across exon-exon splice junctions, shown in Figure 3.23. 
These augmented windows can be inputted from an annotation set, such as 
RefSeq or Ensembl, or from empirical splicing data output from STAR or 
TopHat. These windows specifically avoid the mapping issues at the exon-intron 
boundary, and take into consideration spliced-reads.  
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Figure 3.22 Annotation Supplement Adds Increased Coverage at Exon Ends 
UCSC Genome Browser showing coverage and changes in peaks after 
augmenting spliced windows. Supplementing the traditional MeRIPPeR 
genomic windows with spliced peaks can help extend peaks to the exon edge.  
 
Figure 3.23 Augmented MeRIPPeR Window Method 
The traditional genomic windows are shown in black with an abstract example. 
The addition of spliced windows is shown in the middle and how these spliced 
windows augment the genomic peaks, with the final peaks on the lowest level.   
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3.5 Comparison with Existing Peak Callers 
Using the human data from (Meyer et al., 2012), the peak callers MeRIPPeR, 
exomePeak, and MACS can be compared. Without ground truth to characterize 
the false positives and negatives in each peak caller, the qualitative features of 
the peaks can be compared. All of the peak callers call roughly the same 
number of peaks, as shown below in Figure 3.24, though MeRIPPeR calls the 
most peaks. As was discussed earlier, the raw number of peaks does not 
characterize the sizes of each peak, but a weighted Venn diagram of peak 
regions, weighted by peak size, in Figure 3.25 shows MeRIPPeR still calls the 
most peak regions relative to the other peak callers. Despite these 
characteristics, the global metagene distribution of peaks remains relatively 
unchanged, as shown in Figure 3.26.  
 
Figure 3.24 Number of Peaks Called by Different Peak Callers 
Number of peaks called (y-axis) by each peak caller (x-axis). MeRIPPeR calls 
the most number of peaks, though the characteristics of each peak can be very 
different in the human HEK293 data.  
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Figure 3.25 MeRIPPeR Calls Unique Set of Peaks 
A Venn-diagram weighted by the number of bases called in each peak still 
shows MeRIPPeR calls the most peaks in the Human HEK293 data. 
 
Figure 3.26 Metagene Comparison of Peak Callers  
Metagene distribution showing binned 5’ UTR, CDS, and 3’ UTR for MeRIPPeR-
Default (blue), MeRIPPeR+Genes (cyan), exomePeak (dark green), and MACS 
2 (orange). The metagene distribution shows the peak callers not only 
recapitulate the stop codon enrichment of m6A sites, but that they in part 
produce the same global m6A signature.  
exomePeak MeRIPPeR
MACS2
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The advantage of exomePeak, the authors claim, is its ability to better call peaks 
across splice-junctions by operating in the exonic space. The original 
MeRIPPeR algorithm was built with genomic-based windows, which could miss 
peak regions that may be spliced across an exon-exon splice junction, as 
discussed earlier in 3.4.6 Splice Junctions. The augmented splice-junction 
windows serve to solve that problem, and the method shows that far more 
spliced-peaks are called when using the augmented windows, shown in Figure 
3.27, over the traditional MeRIPPeR algorithm. exomePeak calls the most 
spliced-peaks, and it has the advantage that it reports the peaks as spliced in 
the bed 12 file format, but at the cost of only being able to interrogate exonic 
regions. Figure 3.28 shows the number of bases in peaks mapping to intronic 
and intergenic regions. These peaks may come from immature transcripts, 
novel isoforms and genes, or from retained introns, none of which can be 
interrogated by using the other peak callers.  
The foremost advantage of MeRIPPeR is its implementation in Java, built on 
the htsjdk package, as shown in Figure 3.29. The single-core MeRIPPeR 
performs the fastest read coverage calculations and computes Fisher’s exact 
test very fast with its own internal implementation. MeRIPPeR was also 
designed with multi-core server clusters in mind, and the usage of multiple cores 
enables even faster throughput. exomePeak unfortunately computes the 
coverage in R, which results in a very slow implementation, taking nearly 4.5 
hours to call peaks on the data set, longer than most aligners would have taken 
to align the same data to the genome. 
The authors of exomePeak claim that their advantage is examining peaks in the 
transcriptome space, leading to clear identification of and classification of 
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peaks. They further purport that this reduces ambiguity when dealing with 
multiple transcript isoforms for a single gene and that they can correctly identify 
spliced peaks as a single peak. While directly calculating peaks in the 
transcriptome space does ensure clear gene assignment and spliced peaks, it 
tends to hide the problems they mention, rather than solving them. For example, 
peaks called by exomePeak often overlap with one another, due to overlaps in 
transcript variants of the same gene or overlaps between genes. The same 
genomic region is often assigned to multiple peaks and multiple genes, 
confounding downstream analyses. Essentially, the program maps ambiguous 
regions to all genes and all of their transcript variants. For example, exomePeak 
reports peaks for the gene SLC9A3, as discussed earlier in 3.3.2 Fragment 
Shifting and Extension, a gene that is otherwise not expressed, because of its 
overlap with a different gene, BC013821. While only a few cases similar to gene 
SLC9A3 can be found, the most striking example of finding peaks mapping to a 
gene that is not expressed, there are likely more examples of genes that have 
incorrectly adjusted count-data as an artifact from fragmenting shifting. Working 
within the transcriptomic space has its advantages, but it often hides the 
problems it attempts to solve. By not making assumptions about peak 
assignment to genes and transcripts, these edge cases can be solved, or 
perhaps excluded, during downstream analysis.   
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Figure 3.27 Recovery of Splice Junction Peaks Using Spliced Window 
Augmentation 
The number of potentially spliced-peaks, determined by computing how many 
splice-junctions were spanned by peak regions, shown on y-axis as a function 
of the peak caller on x-axis. MeRIPPeR+Genes calls a higher number of splice 
junctions in peaks by using a gene-annotation to augment genomic-based 
windows with spliced windows.  
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Figure 3.28 exomePeak Captures Little or No Intronic and Intergenic Peaks 
The number of peak bases found in intronic (salmon) and intergenic (teal) 
regions for each peak caller (x-axis), with choice of annotation varying 
horizontally. The advantage of using MeRIPPeR is that it calls the most peaks 
in intronic and intergenic regions. exomePeak’s regions are fixed to the inputted 
gene annotation (UCSC) and the results of using RefSeq to annotate these 
peaks are also shown. MACS2 calls the fewest intronic regions.  
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Figure 3.29 MeRIPPeR is Fastest Peak Caller, exomePeak Slowest 
Runtime of each peak caller, averaged across five tests, shown on y-axis, as a 
function of the peak caller, x-axis. MeRIPPeR is the fastest peak caller, built on 
the htsjdk Java package. exomePeak unfortunately performs its coverage 
calculations in R, which results in it taking nearly 4.5 hours to call peaks, longer 
than most aligners took to align the same data to the genome.  
The RRACH consensus motif was not only initially reported to be associated 
with the METTL3 methyltransferase responsible for methylating adenosine to 
m6A, (Harper et al., 1990; Wei and Moss, 1977a) but was also found in peak 
regions following MeRIP-seq transcriptome-wide mapping. (Dominissini et al., 
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2012; Meyer et al., 2012) With such a high degree of specificity of the motif with 
the methyltransferase, and the presence of the motif in over 80% of the peaks, 
the motif could also be used to determine the potential true positive rate of each 
of the peak finders. Moreover, the motif could be used to determine the veracity 
of the regions in Figure 3.25, showing which peak finders find the most motif-
enriched peaks. Figure 3.30 shows the distribution of the number of times the 
motif appears in the peak regions from Figure 3.25 normalized by peak length, 
demonstrating that exomePeak has poorer performance than MeRIPPeR and 
MACS2. 
 
Figure 3.30 exomePeak Performs Worst in Motif Performance 
Counting the number of RRACH motifs in each of the peak regions in Figure 
3.25 and normalizing by each peak length shows exomePeak performs the 
worst in motif performance, while MACS2 and MeRIPPeR perform comparably.   
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3.6 Conclusions 
Peak calling in MeRIP-seq is highly dependent on a number of variables, 
including the method of RNA purification, the efficiency of the IP, the number of 
rounds of IP, and the accurate alignment of the data to the transcriptome. 
MeRIPPeR is a robust, fast, and powerful peak caller specifically designed for 
MeRIP-Seq data, but has the potential to be applied to other fragmented RNA-
sequencing IP data. Utilizing genomic-based windows, it is not restricted to an 
annotation set or exonic regions, but augmenting spliced-windows from an 
annotation database can aid in identifying spliced-peaks. Without ground truth 
to compare to existing peak callers, using the motif as a measure of truth shows 
that MeRIPPeR and MACS perform equally well. With augmented annotation 
support, MeRIPPeR is specifically designed for MeRIP-seq analysis, with higher 
sensitivity than exomePeak and better sensitivity in spliced peaks than MACS2.   
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CHAPTER 4 DIFFERENTIALLY METHYLATED PEAK REGIONS (DMPRS) 
 
4.1 Introduction 
As was previously mentioned, RNA modifications are dynamic and in addition 
to varying between tissue and cell types, they also respond to changes in cell 
stimuli. Global levels of m6A can be observed to dramatically differ between 
different tissues  (Meyer et al., 2012) and in response to cellular 
stimuli  (Dominissini et al., 2012). Although all the functions of m6A remain 
unknown, it has the potential to function as a dynamic layer of translation 
regulation. Identifying peak regions is the first step in understanding the function 
of m6A: determining where in the genome the sites may lie. Its dynamic nature 
can be further used to elucidate these potential physiological roles. However, 
these are much harder to quantify than changes in DNA methylation and each 
challenge must be appropriately addressed.   
RRBS and other bisulfide chemistry based assays typically achieve nearly 99% 
conversion rates. (Garrett-Bakelman et al., 2015) This not only enables a far 
higher sensitivity in detecting 5mC sites at single nucleotide resolution over an 
antibody immunoprecipitation method, but the exact methylation frequency at 
each base can be estimated as the fraction of cytosines to the total number of 
cytosines and thymines sequenced at each base. Even with biological and 
technical variation between samples and replicates, this fraction can be used to 
accurately find differentially methylated cytosines (DMCs) using logistic 
regression models.  (Akalin et al., 2012) 
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4.2 Challenges in Identifying Differentially Methylated Peak Regions 
However, in the case of m6A and other RNA modifications, calculating 
differentially methylated peak regions is far more complicated due to biological 
and technical variation. The underlying RNA-seq data is observed to have 
increased biological variance and is often modeled with the negative binomial 
over the Poisson model to account for this dispersion. (Robinson et al., 2010) 
This high variance is present in not only the control RNA-Seq samples, but also 
the MeRIP-Seq, complicating estimation of mean methylation levels.  
The total amount of m6A present in a sample can be calculated using an 
immunoblot with the same antibody used to perform the IP pulldown. As has 
been previously demonstrated, the global levels of m6A are vastly different 
between different tissues, such as between the brain and the kidneys. (Meyer 
et al., 2012) Figure 4.1 shows further variation in m6A levels in mice bone 
marrow samples, from a collaboration with Ross Levine, MD. The knockout of 
the Tet2 gene does not have as profound of an impact on global m6A levels as 
the VTF samples, which is a knockout model of Tet2 and Flt3. The plate results 
show biological variance in global m6A levels between different mice samples, 
as well as global changes between different types of mice.  
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Figure 4.1: Global m6A Levels in Mouse Bone Marrow Samples Shows Variation 
Between Sample Types 
Percentage of m6A, normalized by total amount of RNA, in mouse bone marrow 
(BM) samples obtained from Ross Levine, MD and Alan Shih, MD PhD. Tet2 
knockout (KO) had little impact on global m6A levels relative to VTF 
heterozygous (Het) and knockout. VTF is both Tet2 and Flt3. Global m6A levels 
were measured using EpiQuik m6A RNA Methylation Quantification Kit 
(Colorimetric) (Epigentek #P-9005-96). 
Unfortunately, this global amount of methylation is typically not measured or 
noted when performing the MeRIP-Seq protocol, but its impact on both peak 
calling and differential peak calling must be considered. During standard RNA 
sequencing library preparation, libraries are normalized to equimolar 
concentrations, to achieve equal coverage across all RNA transcripts. 
Comparing RNA sequencing data between nuclear and cytosolic fractionated 
RNA samples, for example, does not reflect that the cytosolic fraction contains 
more than 2-3 times more RNA. The increase in m6A content can be the result 
of either an increase in the amount of m6A at each site or an increase in the 
number of m6A sites. Increased methylation at a single site would result in 
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higher enrichment observed at that site. However, an increase in the total 
number of m6A sites would, in theory, mean more RNA fragments being pulled 
down in the IP and result in lower global coverage and enrichment. (Robinson 
and Oshlack, 2010) 
In addition, RNA transcript levels themselves are subject to change between 
replicates and sample conditions. Changes in site-specific m6A levels must be 
normalized for these changes. Moreover, differentially methylated regions 
should have significant changes in the fraction of RNA that is methylated at each 
site. This fraction is more challenging to estimate, as it is dependent on the 
accurate estimation of both the RNA-Seq and MeRIP-Seq levels in each 
window. The MeRIP-Seq fraction is highly variable based on the reproducibility 
of the IP, as well as biological variation in m6A sites.  
Technical variation in MeRIP-Seq can affect both peak calling and differential 
peak estimation. The efficiency of the IP is dependent on numerous factors, 
including the IP binding conditions and the specificity of the antibody. 
Performing all of the IPs in a single batch can reduce some technical variation, 
but as discussed earlier in 3.4.2 MeRIP-Seq IP Enrichment, some technical 
variation will continue to exist between two different replicates.  
Lastly, m6A is a single-nucleotide modification while the resolution of the IP is 
closer to 100-200 base pairs. Each peak has the potential to encompass many 
methylation sites, especially when some peaks can span up to 1,000 base pairs 
or more. (Meyer et al., 2012) This lack of resolution complicates determining 
site-specific methylation changes that might occur. A significant increase or 
decrease in methylation at a single site could be obscured by lack of changes 
in methylation in sites surrounding it. Without explicit single-nucleotide 
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resolution, such as in DNA methylation, the statistical power to find DMRs is 
significantly reduced.   
4.3 Existing Methods in Detecting Differentially Methylated Peak Regions 
Prior to the development of methods to achieve transcriptome-wide mapping of 
m6A, m6A was already known to be a dynamic modification subject to significant 
changes in response to treatments. (Clancy et al., 2002) The first method to 
attempt to look at differentially methylated peak regions in m6A was performed 
by Dominissini et al. when they explored the effect of multiple treatments on 
m6A sites in the HepG2 cell line. They determined that 70-95% of methylation 
sites remained largely unchanged between treatments but were able to find a 
small subset of peaks that did change between treatments, though they 
admitted that their methods were likely very conservative. (Dominissini et al., 
2012)  
Following the publication of the exomePeak Bioconductor package, additional 
methods were built into the method to calculate differentially methylated peak 
regions. The exomePeak method of calling peaks uses a Poisson distribution to 
model the read counts in each of the samples. (Meng et al., 2013) They scale 
the read counts to normalize for the number of reads mapped, show that the 
data follows the hypergeometric distribution, and use Fisher’s Exact Test to test 
for significance, denoted RHtest. (Meng et al., 2014) Two additional methods 
were then developed to detect differential methylation within the exomePeak 
package. RHHMM uses a Bernoulli Hidden Markov-Model (HMM, which they 
claim improves spatial resolution. (Zhang et al., 2014b) The binomial likelihood 
ratio test, bltest, models the data using a binomial distribution and finds 
differentially methylated regions by comparing the means. (Zhang et al., 2014a) 
71 
Unfortunately, the methods are very conservative, with both the RHtest and 
bltest reporting the same five differentially methylated regions in the FTO 
knockout mouse study. (Hess et al., 2013) The methods are also very slow, 
taking over six hours to find the differentially methylated sites.  
4.4 Methods 
Unfortunately, most of the challenges mentioned earlier in identifying 
differentially methylated peak regions are difficult to solve. Normalizing for IP 
efficiency, for example, is confounded by biological variation within the m6A 
sites. Technical replicates, in addition to biological replicates, would be 
preferred, but the costs and input limits are too great to implement them in an 
experimental design. Nevertheless, the best approach is to attempt to normalize 
for some of them, and use quality control metrics to exclude replicates with 
technical artifacts.  
Furthermore, the resolution of MeRIP-seq is on the order of hundreds of base 
pairs, far lower than the single-nucleotide modification. A peak region larger 
than 200 base pairs likely spans multiple m6A sites, but without sufficient data, 
the peak cannot be accurately split into regions encompassing a single site. 
This complicates differential methylation analysis, in that only part of a peak, 
representing a single or perhaps small cluster of m6A sites, may change in 
response to external stimuli. Examining the data at full-peak resolution might 
mask smaller minute changes. To work around this problem, the windowed 
approach, used earlier in Chapter 3.4.2 MeRIP-Seq IP Enrichment to 
demonstrate window enrichment, uses multiple overlapping 100 base pair 
windows that step at 25 base pairs within peak regions to detect smaller 
changes in large peaks. 
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EdgeR, limma, DESeq and other Bioconductor packages have been used 
multiple times with great success in identifying differentially expressed genes 
(DEGs). (Anders and Huber, 2010; Ritchie et al., 2015; Robinson et al., 2010) 
While they theoretically may be used to identify peak regions genome-wide, 
their implementations largely limit their use to annotated genomic regions, on 
the order tens of thousands of genes, for example. Windows within peak 
regions, on the other hand, are far smaller in scale and could be used effectively 
in conjunction with these tools to identify differentially methylated peak regions. 
The tools are already designed to handle RNA-seq data, including normalizing 
for sequencing depth, number of genes expressed, and fitting a linear model. 
The methods below will discuss using EdgeR, but the same methods could be 
applied using limma or DESeq. The edgeR Bioconductor package most notably 
models the underlying RNA-sequencing data using the negative binomial to 
model the dispersion caused by biological variation in the data. This dispersion, 
in particular, is useful in modeling the increased variance caused by the IP.  
Applying the method with the FTO mouse knockout data  (Hess et al., 2013), 
there are two types of mice, wild type and FTO knockout mice, with three 
biological replicates of each. MeRIP-seq was performed on each of them, 
producing six IP samples and six control samples, for a total of 12 sequencing 
samples. The original library sizes were used, to prevent scaling RNA-seq 
libraries to MeRIP-seq depth, and TMM scaling was applied, though separately 
to the IP and Control samples, and merged later, to prevent the same thing 
occurring there. The distribution of the log 2 enrichment without applying TMM 
scaling is shown in Figure 4.2, which shows a high degree of variation in the IP. 
Applying TMM scaling separately to the IP and control samples, the log 2 
distribution of adjusted enrichment counts appears more consistent, depicted in 
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Figure 4.3. The data was modeled within edgeR with the IP nested within the 
mouse type, and differential methylation was applied as a contrast matrix 
comparing the two IP samples. A volcano plot of the results are shown in Figure 
4.4, which compares the log 2 fold change relative to the –log 10 of the raw p-
value. Only four sites actually pass the significance cutoff after p-value 
adjustment, though the windows come from the same peak region. They are 
colored in red on Figure 4.4 and summarized in more detail in Table 4.1. The 
region corresponds to a predicted Ensembl gene ENSMUST00000083437.  
 
Figure 4.2 Distribution of Log 2 Enrichment without Scaling Shows Technical 
Variance in IP Efficiency 
Without applying TMM scaling to scale the control samples and, especially, the 
IP samples, the log 2 enrichment distributions show strong differences in IP 
enrichment. FTO Knockout samples are shown as KO, wild type samples as 
WT, and replicate denoted by number.  
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Figure 4.3 TMM Scaling Normalizes for Technical Variance in Enrichment 
Scaling the read counts for the IP and control samples separately normalizes 
the samples for differences in coverage and IP efficiency. FTO Knockout 
samples are shown as KO, wild type as WT, and replicate denoted by number. 
 
Figure 4.4 EdgeR Differential Methylation Analysis Captures Two DMPRs 
Volcano plot showing the log 2 fold change versus the –log 10 p-value of the 
methylation difference in FTO/WT. The raw p-value is plotted; only two peak 
regions are significant after Benjamini-Hochberg adjustment, denoted in red. 
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Table 4.1: Differentially Methylated Peak Regions in FTO KO Data (edgeR)  
CHR START END LOGFC P-VALUE FDR 
chr10 4484275 4484325 5.618325 2.45E-07 0.008541
chr10 4484250 4484325 5.618325 2.45E-07 0.008541
chr10 4484225 4484325 5.618325 2.45E-07 0.008541
chr10 4484300 4484325 5.558247 1.18E-06 0.030866
 
4.5 Conclusions 
Although the method developed using edgeR failed to capture significantly more 
differentially methylated regions than pre-existing methods, the TMM scaling 
applied to the distribution of log 2 enrichments showed that the method can be 
used to effectively account for differences in IP efficiency. In addition, the p-
value adjustment method uses the Benjamini Hochberg method, which 
assumes statistical independence between the tests. Since the windows are 
overlapping at 25 base pairs, this assumption of independence is no longer 
valid, and the adjustment method is likely over-correcting the family-wise error 
rate. Using a lower cutoff could yield better results but a higher false positive 
rate. Existing methods, such as the bltest and rhtest, capture very few sites, as 
well, but do not account for technical variance in the IP.  
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CHAPTER 5 THE FUNCTIONAL AND PHYSIOLOGICAL ROLE OF METHYL-
6-ADENOSINE IN RESPONSE TO HEAT SHOCK AND RIBAVIRIN 
5.1 Introduction 
Without knowing the function of all of the writers, erasers, and readers of m6A, 
its full physiological role remains unknown. YTDF2 was recognized as one of 
the potential readers, and determined to mediate mRNA decay through p-
bodies. (Wang et al., 2014a) Yet m6A sites are heavily found in nuclear 
RNA, (Levis and Penman, 1978) with its demethylase FTO being found in 
nuclear speckles. (Jia et al., 2011) This implies m6A has the potential for multiple 
roles in gene expression and regulation, further implicating it in 
splicing (Dominissini et al., 2012; Saletore et al., 2013; Zhao et al., 2014) and 
perhaps even nuclear export. Further examining m6A sites in nuclear 
fractionated RNA would serve to answer these questions. 
The antiviral drug ribavirin is a guanosine analogue and traditionally used to 
terminate viral RNA synthesis. (Kentsis et al., 2004) Viral RNA-dependent RNA 
polymerases incorporate ribavirin in place of guanosine, leading to viral 
mutagenesis. (Crotty et al., 2002) In addition, ribavirin was shown to bind to and 
inhibit the eukaryotic translation initiation factor eIF4E, (Kentsis et al., 2004; 
Kentsis et al., 2005) which itself is responsible for recruiting mature mRNA 
transcripts to ribosomes via the 5’ 7-methyl-guanosine cap. (Gingras et al., 
1999) eIF4E is often found elevated in cancer cells, and ribavirin’s inhibition of 
its activities was further shown to aid in the treatment of acute myeloid 
leukemia. (Assouline et al., 2015; Assouline et al., 2009; Borden and Culjkovic-
Kraljacic, 2010) Its repression of the nuclear export of specific mRNAs enables 
it to be specifically used in a controlled experimental design to determine its 
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effect on m6A sites and their potential relationship with the genes that are 
repressed. 
Furthermore, heat shock of cells has been well-studied and characterized as a 
method of cellular stress, including its activation of the heat shock 
proteins.  (Lindquist and Craig, 1988) Its effect on m6A sites was initially 
examined among other treatments,  (Dominissini et al., 2012) and through 
immunoblots was found to a dramatic increase on global levels of m6A.1 The 
immediate export and translation of the heat shock proteins could be further 
used to examine the role of m6A in nuclear RNA.  
5.2 Methods 
The full experimental design served to compare three groups, a control group 
of untreated cells, cells treated with heat shock, and cells treated with ribavirin. 
Each group would consist of total RNA samples, as well as RNA from nuclear 
and cytosolic fractions. Three replicates of each would be used, and MeRIP-
Seq would be performed on each of the samples. In order to meet the minimum 
input requirements for a single round of IP, 50 micrograms of RNA was required 
at a minimum, requiring hundreds of millions of cells to be harvested specifically 
for the nuclear fractionated RNA. Cells from the Ly1 diffuse large B-cell 
lymphoma (DLBCL) cell line were collected by Tharu Fernando, MS of the Ari 
Melnick, MD laboratory, working in collaboration with Leandro Cerchietti, MD. 
Over 1.4 billion cells were required in total to meet the nuclear fractionated RNA 
requirement, and split into 3 fractions for the control, ribavirin, and heat shock 
treatment, before being separated into their individual RNA fractions. The RNA 
samples were fractionated by Tharu Fernando using standard nuclear RNA 
                                            
1 Unpublished data from Kate Meyer, PhD with the Samie Jaffrey, MD PhD laboratory, in 
collaboration with the Ari Melnick, MD laboratory.  
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extraction protocol. Heat shocked samples were heated to 43° C for two hours 
and allowed to recover at 37° C for two hours. Ribavirin cells were treated with 
100 μM ribavirin for four hours. The full experimental design is depicted in Figure 
5.1. 
 
Figure 5.1 Heat Shock and Ribavirin and Nuclear vs Cytosolic MeRIP-Seq 
Experimental Design.  
A full 3x3x3 design with MeRIP-seq and RNA-seq samples resulting in a total 
of 54 samples. Starting with a total of 1.25 billion cells split into three fractions, 
one control, one treated with heat shock, and one treated with ribavirin. Each 
would be further split into three fractions of RNA, total, nuclear, and cytosolic, 
each itself in replicates of three. MeRIP-seq and the control RNA-seq libraries 
were then prepared for each replicate for a total of 54 samples.  
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With 50 micrograms of input material, only a single round of IP was performed 
to ensure all samples resulted in successful libraries, using polyA-purification to 
remove rRNA contamination. Unfortunately, one of the nuclear fractionated heat 
shock replicates was not successful, but its control RNA-seq could still be used 
to estimate RNA-seq levels. The cDNA libraries were then sequenced on an 
Illumina HiSeq 2500 at single-ended 42 base pairs.2  
The sequencing data was aligned to the hg19 genome (excluding haplotype and 
random chromosomes) using the STAR (Dobin et al., 2013) aligner, excluding 
multimapped reads and ensured all samples met quality control specifications 
using R-Make. Peaks were called using MeRIPPeR with augmented junction 
annotation support from RefSeq gene annotations. Peaks were required to be 
present in at least two out of three of the replicates, as opposed to the default 
of requiring it to be present in all replicates, to account for one of the samples 
only having two replicates present.  
5.3 RNA-Sequencing Analysis 
Results from R-Make  (Li et al., 2014a) in Figure 5.2 show that the samples 
were not pooled well and read mapping counts were not equally distributed, with 
one of the ribavirin cytosolic MeRIP samples getting fewer reads. The read 
mapping distribution to gene features was previously discussed in Figure 2.2 as 
proof that polyA-purification of samples results in lower rRNA contamination 
when working with higher RNA input samples. More reads can also be observed 
to map to intronic segments in the nuclear fraction, as can be expected with 
                                            
2 The samples were dual-indexed using a high throughput (HT) Illumina sequencing kit. 
Unfortunately, Illumina does not sell SBS V3 kits with enough bases to sequence the dual 
indexes, so 8 base pairs of the standard 50 base pairs had to be used to sequence the second 
index, leaving only 42 base pairs for each read. SBS V4 kits do have enough reagents but are 
not compatible with the Epigenomics Core sequencers. 
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nuclear fractionated RNA, showing the presence of pre-spliced immature mRNA 
transcripts.  An MDS plot of the samples in Figure 5.3 depicts clear separation 
along the first dimension corresponding to the fraction and the second 
dimension shows separation along the treatments, though the Ribavirin 
treatments do not show a significant change in RNA-Seq from the control.  
 
Figure 5.2 Heat Shock and Ribavirin Read Mapping Distribution  
Distribution of the number of reads mapped (in millions) to each of the samples. 
The third nuclear replicate MeRIP sample failed, which is blank.   
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Figure 5.3 MDS Plot of RNA-Seq data Shows Separation of Fraction and Heat 
Shock 
MDS Plot of RNA-Sequencing data shows a strong separation on the first 
dimension with respect to the fraction. The second dimension shows separation 
of the heat shock samples, but the Ribavirin treatments did not affect the RNA-
Seq levels as much as expected 
However, Ribavirin affects the nuclear export of specific genes, which may be 
masked when examining all of the genes together. In addition, the ideal control 
for the Ribavirin treatment would have been a vehicular control sample. In the 
absence of such a sample, the untreated control sample will have to serve as a 
control. Although this is not ideal, the fact that the samples are globally similar 
to the Ribavirin treated samples in the MDS plot shows that they can still be 
used as an adequate control. 
5.3.1 Heat Shock RNA-Sequencing Analysis 
Unsurprisingly, a volcano plot showing the log 2 fold change versus the -log 10 
p-value of the difference between the heat shock and control samples in the 
total RNA sequencing data in Figure 5.4 shows a large fraction of the genes can 
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be classified as differentially expressed, a total of 1,898 genes out of the 12,508 
genes that were determined to be expressed in the samples3. A heat map of the 
log 2 fold change in expression in genes in the HSP70 gene families shows a 
dramatic increase in HSP70 genes, depicted in Figure 5.5, most of which are 
differentially expressed in all of the fractions. HSPA12A and genes from the 
HSP90 gene family were not in the expressed set of genes and were excluded.  
 
Figure 5.4 Volcano Plot of Heat Shock Total RNA Shows Many Upregulated 
Genes 
Comparison of total RNA-sequencing data between the heat shock and control 
samples shows a large number of differentially expressed genes, shown in red, 
many of which are significantly up-regulated in response to the heat shock.  
                                            
3 Gene expression was determined by requiring a counts per million (CPM) of at least 1 in at 
least 6 of the RNA-Sequencing samples.  
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Figure 5.5 Heat Map of Log 2 Fold Change of HSP70 Genes 
Heat map of the log fold change in genes of the HSP70 gene family shows a 
dramatic increase in their expression relative to the control. Differentially 
expressed genes are denoted in red, log fold change shown for each fraction. 
The changes are consistent across all fractions.  
Figure 5.6 illustrates the concordance of differentially expressed gene sets in 
between the total RNA and nuclear and cytosolic RNA fractions. Unique subsets 
of genes can be found to be differentially expressed in each fraction, with 950 
genes common to all three of them. Gene ontology analysis of the up-regulated 
genes shows an enrichment in both stress response and heat shock, shown in 
Table 5.1 using DAVID. (Huang da et al., 2009a, b) 
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Figure 5.6 Venn Diagram of Differentially Expressed Genes in Fractions Shows 
High Number of DEGs Common to All Fractions 
A Venn diagram showing the overlap of differentially expressed genes found in 
the total RNA-seq and nuclear and cytosolic fractions. Unique subsets of genes 
can be found to be differentially expressed in each subset.  
 
Total 
Nuclear 
Cytosolic 
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Table 5.1: Functional Annotation of Up-Regulated Genes in Heat Shock (Total 
RNA) using DAVID 
Biological Pathway Benjamini P-Value 
phosphoprotein 6.8E-10 
stress response 1.2E-09 
Cytoplasm 2.2E-08 
response to unfolded protein 1.4E-07 
protein folding 1.2E-06 
molecular chaperone 1.6E-06 
Chaperone 1.8E-06 
response to protein stimulus 0.00002 
unfolded protein binding 0.000042 
alternative splicing 0.0005 
positive regulation of programmed cell death 0.002 
regulation of apoptosis 0.002 
positive regulation of cell death 0.002 
positive regulation of apoptosis 0.0021 
cell death 0.0021 
Death 0.0022 
regulation of cell death 0.0024 
regulation of programmed cell death 0.0025 
Apoptosis 0.0039 
programmed cell death 0.0054 
Dioxygenase 0.008 
response to organic substance 0.0087 
intracellular signaling cascade 0.0098 
protein kinase cascade 0.012 
splice variant 0.013 
heat shock 0.02 
atp-binding 0.02 
Nucleus 0.022 
protein amino acid phosphorylation 0.037 
nucleotide-binding 0.042 
mutagenesis site 0.044 
compositionally biased region:Glu-rich 0.046 
developmental protein 0.05 
 
The fractionated data can be used to identify genes that have significant 
changes in their nuclear to cytosolic ratios, the volcano plot of which is depicted 
in Figure 5.4.  Although a fair number of genes are deemed differentially 
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exported, pathway analysis does not indicate an enrichment of any specific 
pathways. The differentially exported genes and their log fold change in the 
nuclear/cytosolic ratio is shown in Figure 5.8. However, the analysis of 
differential export is more suited for the Ribavirin treated samples, although it 
can still be examined in the context of the heat shock treatments.  
 
Figure 5.7 Heat Shock Induces Some Significant Changes in Nuclear/Cytosolic 
Ratio 
A volcano plot showing the log 2 fold change in the change in the fraction of 
nuclear to cytosolic levels and the -log 10 adjusted p-value. Genes showing 
significant nuclear/cytosolic ratio are shown in red. 
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Figure 5.8 Log Fold Change in Heat Shock Nuclear to Cytosolic Ratio 
A heat map showing the log fold change of the nuclear to cytosolic ratio for 
genes that were determined to be differentially exported.  
5.3.2 Ribavirin Treatment RNA-Sequencing Analysis 
The multi-dimensional scaling plot in Figure 5.3 showed very little change in the 
RNA-sequencing data in the Ribavirin treated samples, relative to the control. A 
principal components analysis (PCA) of only the Ribavirin and control samples, 
excluding the heat shock samples, shown in Figure 5.9, shows the first two 
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dimensions separate the samples along the fractionation. The Ribavirin treated 
samples still remain tightly clustered with the control samples. A scree plot of 
the variance in the PCA analysis, Figure 5.10, shows that these first two 
dimensions capture the vast majority of the variance, and additional dimensions 
do not result in clear separation of the Ribavirin treatments. Consequently, no 
genes are found to be differentially expressed in any of the fractions, so only a 
smear plot of the average log counts per million of each gene and its log fold 
change in the Ribavirin treatment is shown in Figure 5.11 for reference.  
 
Figure 5.9 Ribavirin and Control Samples Remain Tightly Clustered 
Principal Component Analysis of the counts per million in the Ribavirin and 
control samples separates the samples on the first and second dimensions 
along the fractionation.  
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Figure 5.10 Majority of Differences in Ribavirin Treatments in Fractionation 
Scree plot showing the variance in each dimension of the PCA analysis of the 
Ribavirin and Control treated samples. The first two components clearly capture 
the majority of the variance.  
 
Figure 5.11 Ribavirin Smear Plot 
A smear plot showing the average log counts per million (CPM) of each gene 
and its log fold change in the Ribavirin treatment, for each fraction. No genes 
were found to be differentially expressed.  
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5.3.3 Heat Shock vs Ribavirin RNA-Sequencing 
However, the ribavirin treatment can also be viewed as the opposite of the heat 
shock treatment. Heat shock stimulation induces heat shock and stress 
response, simulating B-cell activation. Ribavirin, on the other hand, prevents the 
nuclear export of genes, specifically genes implicated in stress response. 
Comparing the RNA-sequencing data from these two treatments, in particular, 
shows far more up-regulation of heat and stress response genes in the heat 
shock samples, as expected, depicted below in Table 5.2, using GOrilla gene 
ontology. (Eden et al., 2007; Eden et al., 2009) 
Table 5.2: Gene Ontology Pathway Enrichment in Heat Shock vs Ribavirin 
Description P-value FDR q-value
response to unfolded protein 1.07E-16 1.23E-12 
response to topologically incorrect protein 1.00E-15 5.80E-12 
protein folding 3.02E-14 1.16E-10 
protein refolding 7.90E-14 2.28E-10 
negative regulation of inclusion body assembly 5.24E-09 1.21E-05 
response to heat 8.79E-09 1.69E-05 
response to temperature stimulus 2.03E-08 3.35E-05 
regulation of cellular response to heat 2.12E-08 3.07E-05 
cellular response to heat 3.17E-08 4.07E-05 
response to chemical 3.19E-08 3.69E-05 
regulation of inclusion body assembly 1.16E-07 1.22E-04 
response to organic substance 3.98E-07 3.83E-04 
chaperone-mediated protein folding 1.01E-06 9.01E-04 
alpha-amino acid metabolic process 1.33E-06 1.10E-03 
 
5.4 MeRIP-Seq Analysis 
5.4.1 MeRIPPeR Peak Calling and Quality Control Metrics 
The number of peaks called using MeRIPPeR is depicted in Figure 5.12. The 
control and ribavirin samples are consistent with previous studies that higher 
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concentrations of m6A can be found in nuclear RNA, with the exception of the 
heat shock sample, which could be attributed to the loss of one of the nuclear 
MeRIP sample replicates. The peak enrichment was calculated by dividing the 
number of normalized MeRIP reads by the number of control RNA-seq reads 
for each sample replicate. Replicates are normalized by the total number of 
reads mapped, to account for differences in sequencing depth, and using the 
trimmed mean method (TMM) (Robinson and Oshlack, 2010) from 
edgeR  (Robinson et al., 2010) to account for differences in the number of 
expressed fragments in each sample.4  
The density distribution of log 2 normalized peak enrichment scores for peaks 
present in at least six out of the nine (two-thirds) of the samples is shown in 
Figure 5.13, which shows most of the MeRIP samples had similar IP 
efficiencies. However, the third cytosolic heat shock replicate and the first 
nuclear heat shock replicate show some major batch effects, with the third 
cytosolic heat shock replicate showing many peaks with low peak enrichment 
scores indicating a poorer IP pulldown efficiency. Figure 5.14 depicts a violin 
plot of the same enrichment scores. The density plot is useful for examining 
technical variance in the IP and the violin plot is better for visualizing dramatic 
shifts in the mean global IP efficiency. TMM scaling adjusts for some of the 
technical variance in the data.    
                                            
4 TMM scaling was calculated independently for the MeRIP and control samples to prevent 
scaling MeRIP samples to RNA-seq counts.  
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Figure 5.12 Increased Peaks Found in Nuclear Samples 
The number of peaks called varies with respect to the sample, depending on 
the amount of m6A present, the efficiency of the IP, and other factors. More 
peaks were called in the nuclear fraction, with the exception of the heat shock 
sample that had fewer peaks called overall.  
 
Figure 5.13 Variation in Peak Enrichment Density  
The density distribution of the log 2 peak enrichment of the peaks found in at 
least six of the nine different samples. Most of the replicates show a consistent 
distribution after TMM scaling, but some replicates show low IP efficiency.  
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Figure 5.14 Adjusted Peak Enrichments Normalize for Technical Variation  
A violin plot shows the same data as the density plot, but the density plot is 
useful for determining technical and biological variance, while the violin plot 
shows the mean IP efficiency more clearly. All of the samples have roughly the 
same IP efficiency, once normalized by sequencing depth and TMM scaling, 
though the high variance in replicates can still be observed.  
The samples show similar distributions with respect to each other in the 
metagene plot of the peaks called, depicted in Figure 5.15. The plot is very 
sensitive to the number of peaks called, with fewer peaks called resulting in 
increased noise and a smaller signal in the 5’ UTR. The figure recapitulates the 
enrichment of peaks found at the stop codon, as well as a smaller enrichment 
present in the first coding sequence exon. Principal component analysis (PCA) 
of the peak enrichment scores is shown in Figure 5.16 and its corresponding 
scree plot depicting the dimensional variances in Figure 5.17. The first 
dimension itself captures nearly 64% of the variance, and shows the samples 
clustering together with those replicates showing batch effects as outliers. The 
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peak enrichments do not cluster in a meaningful pattern, especially with regards 
to replicates, which could complicate downstream analysis.  
 
 
Figure 5.15 Peak Enrichment at Stop Codon and in First CDS 
The metagene plot shows the distribution of peaks across a meta-genebody, 
with the 5’ UTR and 3’ UTR segments plotted separately. This particular version 
plots the first and last exon separately (bottom), with one and two-exon genes 
being plotted separately (top).   
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Figure 5.16 PCA of Peak Enrichments in Ribavirin/Heat Shock Samples 
Principal Component Analysis (PCA) shows separation along the first 
dimension of samples, but the sample replicates do not cluster as well together, 
indicating poor IP replicability.  
 
Figure 5.17 First Dimension Captures Majority of Variance in Heat Shock PCA 
A scree plot of the PCA analysis of the peak enrichment in the Ribavirin and 
heat shock samples shows most of the variance in the first dimension.  
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5.4.2 Differentially Methylated Peak Regions in Heat Shock 
Differentially methylated peak regions (DPMRs) were identified using the 
methods defined earlier in Chapter 4 Differentially Methylated Peak Regions 
(DMPRs), with a 100 base pair sliding windows stepped at 25 base pairs across 
the union of all peaks, using edgeR to analyze the count data and TMM scaling 
to adjust for IP efficiency and RNA-sequencing library sizes.  (Quinlan and Hall, 
2010; Robinson et al., 2010; Robinson and Oshlack, 2010) No peaks regions 
were identified to be differentially methylated in the heat shock total RNA 
samples, but a large subset of windows were identified as differentially 
methylated in the cytosolic and nuclear fractions, shown below in volcano plots 
in Figure 5.18 and Figure 5.19, respectively.  
 
Figure 5.18 Volcano Plot of Differentially Methylated Windows in Heat Shock 
Cytosolic RNA 
A volcano plot comparing the log 2 fold change to and the Benjamini-Hochberg 
adjusted -log 10 p-value of peak windows in the heat shock cytosolic RNA 
samples compared to the control cytosolic samples. Differentially methylated 
regions are denoted in red.  
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Figure 5.19 Volcano Plot of Differentially Methylated Windows in Heat Shock 
Nuclear RNA 
A volcano plot comparing the log 2 fold change to and the Benjamini-Hochberg 
adjusted -log 10 p-value of peak windows in the heat shock nuclear RNA 
samples compared to the control cytosolic samples. Differentially methylated 
regions are denoted in red. Fewer windows are differentially methylated relative 
to the cytosolic fraction.  
Annotating these regions to genes, the metagene distribution of the DMPRs, 
plotted separately for hypermethylated and hypomethylated regions, is shown 
in Figure 5.20 for the cytosolic fraction and Figure 5.21 for the nuclear fraction. 
Identifying fewer DMPRs results in a noisier signal, such as the 
hypermethylated regions in the heat shock cytosolic vs nuclear fractions. 
However, there does appear to be a strong signal of hypomethylation in the 
cytosol and hypermethylation in the nucleus around the stop codon, as well as 
hypomethylation in the 5’ UTR and first coding sequence exon in the cytosol 
and nucleus.  
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Figure 5.20 Heat Shock DMPRs in Cytosol shows Hypomethylation in First 
CDS, Hypermethylation at Stop Codon 
A binned metagene shows the distribution of differentially methylated peak 
regions mapped to gene features, with the first and last coding exons plotted 
separately. Genes with two and fewer exons are plotted separately on top in the 
traditional metagene plot. Heat Shock DMPRs in the Cytosolic fraction show a 
strong hypomethylation signal in the first coding sequence and 5’ UTR and a 
hypermethylation signal at the stop codon.  
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Figure 5.21 Heat Shock DMPRs in Nucleus shows Hypomethylation in First 
CDS, Hypermethylation at Stop Codon 
A binned metagene shows the distribution of differentially methylated peak 
regions mapped to gene features, with the first and last coding exons plotted 
separately. Genes with two and fewer exons are plotted separately on top in the 
traditional metagene plot. Heat Shock DMPRs in the Nuclear fraction show a 
strong hypomethylation signal in the first coding sequence and 5’ UTR and a 
hypermethylation signal at the stop codon. With fewer DMPRs in the nucleus 
fraction than in the cytosolic, the level of noise is increased.  
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To determine if there is in fact a correlation between a type of hyper- or hypo-
methylation and the change in nuclear export, Figure 5.22 shows the distribution 
of the log fold change in the nuclear to cytosolic ratio in the heat shock samples 
for each gene feature and change in direction, separately. Most of the 
distributions are centered on 0, indicating no correlation, with the exception of 
differentially methylated peaks in intronic regions. Hypomethylated DMPRs in 
introns are correlated with a decrease in the mRNA nuclear to cytosolic ratio, 
while hypermethylated DMPRs in introns show the opposite.  
In other words, the change in methylation in introns is correlated with the change 
in the mRNA nuclear/cytosolic fraction. However, DMPRs in the 
nuclear/cytosolic ratio are dependent on the mRNA nuclear/cytosolic fraction, 
to account for changes in mRNA levels to determine the change in methylation. 
A very small shift, but not statistically significant, can be observed in the other 
gene features for the nuclear/cytosolic DMPRs, but none of them are as 
significant as the change in the intronic DMPRs, indicating that this correlation 
is not because of the dependency. 
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Figure 5.22 Boxplot of Heat Shock Log Fold Change in Nuclear/Cytosolic RNA-
Seq Ratio by Heat Shock DMPR Gene Annotations  
The x-axis is the gene feature to which a DMPR was annotated and the y-axis 
is the log fold change of the nuclear/cytosolic ratio in the RNA-sequencing data 
analyzed earlier, separated by the DMPR type and direction. Most of the 
distributions are relatively the same, with the means still remaining between the 
quartiles, with the exception of hypomethylation in the intron correlated with 
decreased nuclear/cytosolic log fold change.  
5.4.3 Differentially Methylated Peak Regions in Ribavirin Treatment 
The Ribavirin treated samples do not show as significant changes as the heat 
shock samples, both in the RNA-sequencing, as well as in the IP. No DMPRs 
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were found in either the Ribavirin total, cytosolic, or nuclear fractions. The 
Ribavirin nuclear/cytosolic DMPR analysis did, however, produce many 
DMPRs, as shown in Figure 5.23. The metagene distribution of these DMPRs 
is shown in Figure 5.24, showing an enrichment of hypomethylation at the stop 
codon. The boxplot comparison of annotated gene features to the 
nuclear/cytosolic log fold change, similar to Figure 5.22 discussed earlier, in 
Figure 5.25 does not recapitulate the results from 5.4.2 Differentially Methylated 
Peak Regions in Heat Shock.  
 
Figure 5.23 Volcano Plot of Differentially Methylated Windows in Ribavirin 
Cytosolic vs Nuclear Fractions 
A volcano plot comparing the log 2 fold change to and the Benjamini-Hochberg 
adjusted -log 10 p-value of peak windows in the Ribavirin treated samples 
nuclear to cytosolic fractions compared to that of the control cytosolic samples. 
Differentially methylated regions are denoted in red.  
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Figure 5.24 Metagene plot of Differentially Methylated Windows in Ribavirin 
Metagene plot showing the profile of differentially methylated peak window 
regions in the Ribavirin treatment cytosolic versus nuclear fraction. 
Hypomethylation is enriched at the stop codon and in the 3’ UTR, while 
hypermethylation doesn’t have a consistent metagene profile.   
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Figure 5.25 Boxplot of Ribavirin Log Fold Change in Nuclear/Cytosolic RNA-
Seq Ratio by Ribavirin DMPR Gene Annotations  
The x-axis is the gene feature to which a DMPR was annotated and the y-axis 
is the log fold change of the nuclear/cytosolic ratio in the RNA-sequencing data 
analyzed earlier, separated by the DMPR type and direction. This distribution 
does not recapitulate the pattern observed earlier in Figure 5.22.  
5.4.4 Differentially Methylated Peak Regions in Heat Shock vs Ribavirin 
Previously, RNA-sequencing data was compared between the heat shock and 
ribavirin treatments, and similar comparisons can be made with the differentially 
methylated peak regions. Depicted in Figure 5.26, the volcano plot shows most 
of the regions are hypomethylated in the heat shock sample, with most of these 
regions mapping to the stop codon and 3’ UTR. Table 5.3 illustrates the pathway 
enrichment for the genes that these regions map to, which includes many RNA 
regulatory and splicing pathways. This demonstrates that m6A has the potential 
to be directly involved in these regulatory pathways, further corroborated by 
similar results in the nuclear fraction.  
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Table 5.3: Gene Ontology Pathway Enrichment Genes with Differentially 
Methylated Peak Regions in Heat Shock vs Ribavirin in Total RNA 
Description P-value FDR q-value
nucleic acid metabolic process 3.51E-26 4.05E-22 
RNA metabolic process 2.34E-24 1.35E-20 
cellular macromolecule metabolic process 1.26E-23 4.86E-20 
nucleobase-containing compound metabolic 
process 
2.8E-23 8.1E-20 
heterocycle metabolic process 5.97E-22 1.38E-18 
cellular aromatic compound metabolic process 9.67E-22 1.86E-18 
organic cyclic compound metabolic process 7.2E-21 1.19E-17 
regulation of gene expression 2.04E-20 2.95E-17 
regulation of cellular macromolecule biosynthetic 
process 
3.34E-20 4.29E-17 
regulation of macromolecule biosynthetic process 7.34E-20 8.48E-17 
macromolecule metabolic process 1.3E-19 1.36E-16 
regulation of biosynthetic process 5.75E-19 5.53E-16 
regulation of cellular biosynthetic process 9.35E-19 8.31E-16 
macromolecule biosynthetic process 7.67E-18 6.33E-15 
regulation of nucleobase-containing compound 
metabolic process 
1.09E-17 8.43E-15 
cellular macromolecule biosynthetic process 2.25E-17 1.63E-14 
cellular nitrogen compound metabolic process 4.17E-17 2.84E-14 
regulation of metabolic process 5.53E-17 3.55E-14 
regulation of cellular metabolic process 6.27E-17 3.81E-14 
regulation of macromolecule metabolic process 6.93E-17 4E-14 
regulation of nitrogen compound metabolic 
process 
2.88E-16 1.58E-13 
regulation of RNA metabolic process 4.72E-16 2.48E-13 
regulation of transcription, DNA-templated 1.12E-15 5.61E-13 
regulation of primary metabolic process 2.06E-15 9.93E-13 
regulation of RNA biosynthetic process 2.23E-15 1.03E-12 
regulation of nucleic acid-templated transcription 2.56E-15 1.14E-12 
nitrogen compound metabolic process 6.7E-15 2.87E-12 
RNA biosynthetic process 8.03E-14 3.32E-11 
transcription, DNA-templated 1.13E-13 4.49E-11 
nucleic acid-templated transcription 1.21E-13 4.66E-11 
RNA processing 1.03E-12 3.84E-10 
nucleobase-containing compound biosynthetic 
process 
3.03E-12 1.09E-09 
primary metabolic process 7.2E-12 2.52E-09 
RNA splicing 8.34E-12 2.83E-09 
heterocycle biosynthetic process 1.68E-11 5.54E-09 
aromatic compound biosynthetic process 1.74E-11 5.59E-09 
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Figure 5.26 Volcano Plot of Differentially Methylated Windows in Heat Shock vs 
Ribavirin Total RNA 
A volcano plot comparing the log 2 fold change to and the Benjamini-Hochberg 
adjusted -log 10 p-value of peak windows in the heat shock vs ribavirin 
treatment total RNA. Differentially methylated regions are denoted in red.  
5.5 Discussion and Conclusions 
Multiple comparisons can be made within the extensive experimental design to 
examine the role of heat shock and Ribavirin treatments in m6A in the context 
of nuclear and cytosolic RNAs. The heat shock treatments induced a dramatic 
response, as expected, with many genes up-regulated in pathways responding 
to temperature and heat response, including genes in the HSP70 gene family. 
The ribavirin treatments serve as the opposite to the heat shock, restricting the 
nuclear export of genes particularly involved in stress response. Although, the 
ribavirin treatments did not significantly affect the RNA-sequencing expression 
levels of genes relative to the control samples.  
Differentially methylated peaks in the heat shock samples were correlated with 
changes in the nuclear to cytosolic ratio, indicating that m6A could play a role in 
107 
nuclear export of mRNAs. Comparing these results with EIF4E IPs, for example, 
could help in connecting the pathways. Ribavirin is known to affect the nuclear 
export of specific genes, such as BCL6 and BCL2,5 but these genes were not 
significantly impacted in the RNA-sequencing data. The original results were 
based on qPCR data, and RNA-sequencing often have higher variance, 
confounding analysis.   
Heat shock stimulation is a widely-studied form of stress response, and 
specifically used in B-cell cell lines to simulate B-cell activation. Ribavirin 
interacts with EIF4E, preventing the nuclear export of many of the stress 
response genes up-regulated in heat shock treatment. Comparing the two 
treatments, the RNA-sequencing data showed a strong enrichment for genes 
involved in heat and stress response pathways. The MeRIP-Seq data showed 
a strong hypomethylation signal, primarily near the stop codon and 3’ UTR, in 
genes corresponding to RNA regulatory pathways, including splicing. While 
YTHDF2 has been studied as an m6A reader in the cytosol (Wang et al., 2014a), 
this does not explain the function of m6A in the nucleus. The treatment data and 
comparisons show that m6A sites change dramatically in genes responsible for 
RNA regulation, export, and splicing. Identifying nuclear-specific readers could 
help further elucidate its exact functional role.  
                                            
5 Unpublished data from Leandro Cerchietti, MD and Katherine Borden, PhD.   
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CHAPTER 6 THE ROLE OF METHYL-6-ADENOSINE IN ADIPOGENESIS: A 
CASE STUDY IN PORCINE MODEL 
6.1 Introduction 
The fat mass and obesity associated FTO gene was discovered to be one of 
the demethylases of methyl-6-adenosine. (Jia et al., 2011) Similar in structure 
to the AlkB family of DNA demethylases,  (Gerken et al., 2007) FTO is also an 
alpha-ketoglutarate and iron (II) dependent dioxygenase. Specific alleles of the 
FTO gene were found to be correlated with obesity in humans,  (Frayling et al., 
2007; Yang et al., 2012) further implicating m6A in adipogenesis. These 
implications were confirmed by further experiments in mouse cell lines, where 
FTO levels were found to decrease and m6A content increased as fat cells 
matured. (Zhao et al., 2014) 
Although m6A has not yet been profiled in the porcine model, GWAS studies 
have found similar correlations with FTO and fat mass across different pig 
breeds. (Fan et al., 2009; Fontanesi et al., 2010; Fontanesi et al., 2009) The 
Jinhua breed of pigs is native to China, with superior meat quality and slow 
muscle growth compared to the faster-growing and leaner Danish breed, 
Landrace. (Miao et al., 2009) Jinhua pigs exhibit an intramuscular fat (IMF) 
content of around 4.54%, compared to 1.43% in Landrace pigs, (Guo et al., 
2011) which not only explains the higher meat quality, but can be used as the 
perfect model to study m6A in the context of adipogenesis. In addition, global 
m6A levels have been found to be anti-correlated with adipose levels, with 
increased expression of FTO and decreased m6A levels in samples with higher 
tri-glyceride and fat content than those with lower.6 
                                            
6 Unpublished data in collaboration with Xinxia Wang, PhD and Yizhen Wang, PhD.  
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6.2 Methods 
Tissue samples from three different biological replicates of Jinhua and Landrace 
pigs, each, were taken from the soleus and tibialis anterior muscle, in 
collaboration with Qing Wu Shen, PhD, Xinxia Wang, PhD, and Yizhen Wang, 
PhD. RNA was extracted and polyA-purified, and a single round of MeRIP-Seq 
was performed on the samples. Following Illumina TruSeq Stranded RNA library 
preparation, libraries were sequenced on four lanes at single-ended 50 base 
pairs on an Illumina HiSeq 2500 sequencer. 
6.3 Results  
6.3.1 Distribution of Reads and m6A Peaks 
The distribution of reads sequenced is shown in Figure 6.1, which shows a 
variable amount of ribosomal contamination and decreased 5’ UTR 
representation, which could be indicative of both poor polyA-purification and 
RNA quality. The MeRIP samples also do not show as dramatic of a shift in read 
distributions compared to other samples, which could be due to poorer IP 
efficiency but most likely the lower sequencing depth. The number of peaks 
called by MeRIPPeR is shown in Figure 6.2, with relatively few peaks being 
called compared to previous studies, most likely due to the low sequencing 
depth. The distribution of these peaks to gene features is shown in Figure 6.3, 
with most peaks mapping to intergenic regions, as can be expected from the 
read distribution in Figure 6.1.  
Peaks were called by requiring presence in at least two of three replicates, 
because of lack of replicates and poorer IP efficiency. The distribution of peak 
enrichment is depicted in Figure 6.4, which shows a lack of concordance 
between replicates in the Jinhua Tibialis Anterior and Landrace Soleus samples, 
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which partially explain the few number of peaks called in those samples (Figure 
6.2). The peak enrichments were computed by taking the union of all peaks; 
differentially methylated peaks are likely to be found towards the maximum and 
minimum edges. Despite taking the union, most peak windows do still show a 
positive peak enrichment, indicating that few peaks show significant 
demethylation when comparing the samples. The metagene distribution of 
reads depicted in Figure 6.5 do not show significant enrichments around the 3’ 
UTR or transcription start site (TSS).  
 
Figure 6.1 Increased Reads Mapping to Intergenic Regions 
Pie charts showing the distribution of reads mapping to gene features, with 
intergenic in salmon, introns in dark yellow, exonic regions in dark green, 5’ UTR 
in cyan, 3’ UTR in blue, and ribosomal in pink. Most of the reads map to 
intergenic regions in the porcine model using RefSeq annotations, perhaps 
coming from genes that have yet to be annotated.  
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Figure 6.2 High Variation in Number of Called Peaks 
Number of total peaks called per sample, after requiring replicates be present 
in at least two of three replicates. Relatively fewer peaks were called in the 
Landrace Soleus sample, with few peaks called overall compare to IPs in other 
species.  
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Figure 6.3 Increased Number of Peaks mapping to Intergenic Regions 
Pie charts showing the distribution of peaks called mapping to gene features, 
with intergenic in salmon, introns in dark yellow, exonic regions in dark green, 
5’ UTR in cyan, 3’ UTR in blue, and ribosomal in pink. The distribution of peaks 
called to gene features shows most peaks mapping to intergenic regions and 
very few peaks to ribosomal regions. Fewer peaks mapped to the 3’ UTR than 
previous studies.  
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Figure 6.4 Low Replicability in Landrace Soleus Explains Low Peak Numbers 
The density of peak enrichment scores for each replicate is shown, with the 
numbered replicates shown as red, blue, and green, respectively. Peak 
enrichment density shows most peaks are enriched to the same degree, 
indicating a successful IP. The peak distributions are most correlated in the 
Jinhua Soleus sample, with worse replicability the Jinhua Tibialis Anterior and 
Landrace Soleus samples, correlated with lower number of peaks called. 
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Figure 6.5 Read Metagene Affected by Lack of Annotation 
Metagene distribution of reads mapped to gene features does not show a 
significant increased around the transcription start site or stop codon. With most 
peaks mapping to unannotated intergenic regions, the amount of signal present 
is far lower.  
6.3.2 Differentially Expressed Genes 
The MeRIP-seq protocol (Meyer et al., 2012) requires a normal control RNA-
sequencing sample for each MeRIP-Seq sample to normalize for transcript 
abundances in each replicate. In a larger experimental design, such as the two 
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by two study in the porcine model, this data can provide additional information 
on differentially expressed genes between samples. A multidimensional scaling 
(MDS) plot that minimizes distances between the normalized gene counts, 
Figure 6.6, shows a clear separation in the RNA-seq data on the first dimension 
with respect to the species. The separation on the second-dimension shows 
some separation with respect to the tissue, with the exception of the Jinhua 
tibialis anterior replicate one.  
 
Figure 6.6 MDS Plot Clusters Samples by Species and Tissue 
Multi-Dimensional Scaling (MDS) plot of the RNA-seq data shows a clear 
separation by species, with Jinhua and Landrace separated by the first 
dimension on the x-axis. The data is somewhat separated by tissue, with the 
exception of the Jinhua tibialis anterior replicate 1.   
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A volcano plot comparing the log 2 fold change and the adjusted p-value is 
shown below in Figure 6.7, which shows more than half of the genes appear to 
be differentially expressed between the two species. Volcano plots comparing 
the individual tissues separately produced similar results, though the focus is 
on comparing the two species. The samples are two dissimilar with too many 
differentially expressed genes for gene ontology and pathway analysis.  
 
Figure 6.7 Large Number of Differentially Expressed Genes Between Species 
A volcano plot showing the log2 fold change between the two species, Landrace 
and Jinhua, and the Benjamini-Hochberg adjusted p-value. Differentially 
expressed genes (p-value cutoff of 0.05) are shown in red.  
6.3.3 Differentially Methylated Peaks 
Differentially methylated peak regions were found using the windows from 
Figure 6.4 and the methods outlined previously in Chapter 4 Differentially 
Methylated Peak Regions (DMPRs). Using the edgeR Bioconductor package, 
TMM scaling was applied for the MeRIP-Seq and control samples separately, 
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and the subsequent adjusted log 2 enrichment distribution is shown in Figure 
6.8, showing similar means of enrichment in the IPs across replicates. Volcano 
plots for differentially methylated peak regions in the soleus and tibialis anterior 
tissues are in Figure 6.9 and Figure 6.10, respectively. Multiple differentially 
methylated peak regions were found using a p-value cutoff of 0.10 and 
annotated to known genes.  
 
Figure 6.8 Adjusted Peak Enrichment Removes Technical Variance 
Trimmed-Mean Method (TMM) Scaling shows the mean enrichment levels are 
normalized for differences observed earlier in IP efficiencies.  
The soleus samples showed significant hypermethylation in gene annotations 
in the Jinhua relative to the Landrace, specifically in genes PCMT1, TPM2, 
RPL35, RPL27, RPL26, TNNC1, FDFT1, MYOZ1, RPL36, COX8H, TMOD4, 
BOLA1, RPL5, CALM3, GPANK1, RPS3A, and RPS4. The only gene that was 
hypomethylated was RN18S from ribosomal RNA. In contrast, there was 
significant hypomethylation in the tibialis anterior samples, especially in the 
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genes TPM2, RPL32, CAPZA2, RPL36, OAZ1, MDH2, TCTP, ITIH2, IDH2, and 
MB, while hypermethylation was observed in RN18S and RYR1. Detection of 
methylation changes in ribosomal RNAs are likely the result of ribosomal RNA 
contamination from the relatively poor polyA purification observed earlier.  
 
Figure 6.9 Differentially Methylated Peak Regions Between Species in Soleus 
Muscle 
A volcano plot showing the log2 fold change and the Benjamini-Hochberg 
adjusted p-value between the Jinhua and Landrace species in the soleus 
muscle. Differentially expressed genes (p-value cutoff of 0.05) are shown in red.  
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Figure 6.10 Differentially Methylated Peak Regions Between Species in Tibialis 
Anterior Muscle  
A volcano plot showing the log2 fold change and the Benjamini-Hochberg 
adjusted p-value between the Jinhua and Landrace species in the tibialis 
anterior muscle. Differentially expressed genes (p-value cutoff of 0.05) are 
shown in red.  
 
Figure 6.11 Gene Ontology Analysis of Hypermethylated Genes in the Soleus  
Gene ontology analysis using DAVID of hypermethylated genes from the soleus 
samples.  
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Figure 6.12 Gene Ontology Analysis of Hypomethylated Genes in the Tibialis 
Anterior  
Gene ontology analysis using DAVID of hypomethylated genes from the Tibialis 
Anterior samples.  
6.4 Conclusion 
Here we present the epitranscriptome of the porcine model, confirming the 
eukaryotic enrichment of m6A sites near the stop codon. Global m6A levels have 
been found to be anti-correlated with adipogenesis, in addition to m6A sites 
required for adipogenesis. (Zhao et al., 2014) With further biological 
experiments comparing the knockdown of METTL3 or FTO, these DMPRs could 
have greater biological meaning and significance.  
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CHAPTER 7 CONCLUSION 
 
7.1 Summary 
Although RNA modifications have been known to exist for many years, only 
recently was the door opened to transcriptome-wide mapping methyl-6-
adenosine. Shortly thereafter, the epitranscriptome expanded to include 5-
methyl-cytidine in RNA, and the field continues to grow, exploring over 100 RNA 
modifications present.  (Agris et al.; Cantara et al., 2011; Saletore et al., 2013) 
While we await the development of chemically-based methods, MeRIP-seq and 
MeRIPPeR combine an immunoprecipitation antibody-based enrichment 
protocol with a robust peak finder to find m6A sites throughout the transcriptome. 
Each new epi-layer unveils a new level of transcriptional and translational 
regulation, and the full functional role of methyl-6-adenosine has yet to be 
discovered.  
MeRIP-Seq and m6A-seq are fully published protocols, with many new groups 
applying the same methods in new species and cell lines. In Chapter 2, I 
examined the protocol in more detail, identifying sources of bias and sample 
loss, such as the impact of ribosomal RNA contamination. The greatest 
challenge in m6A experiments is the enormous input limit required, preventing 
analysis of clinical samples. Using a titration test, I determined not only the input 
limits of the protocol, but the consequences of using lower inputs, and how to 
achieve better IP enrichment.  
In Chapter 3, I introduced MeRIPPeR as a MeRIP-Seq peak finder, designed to 
identify putative m6A sites in the genome. Each step, from the decisions made 
during the MeRIP-Seq protocol to choices made on the computational side, has 
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an impact on the nature of the peaks called, and I explored the consequences 
of some of them, including the choice of aligner used, handling spliced data and 
spliced peaks, and correcting for ribosomal RNA contamination. I further 
explored biases that are introduced in the protocol, including the efficiency of 
the IP, and how that affects peak calling. I analyzed the data from the input 
titration test to compare the impact of using lower RNA inputs and the benefit of 
using two rounds of IP. Lastly, I compared the results and performance of 
MeRIPPeR against exomePeak, another m6A-specific peak finder, and MACS2, 
and determined that MeRIPPeR called peaks the fastest and with the highest 
sensitivity.  
I expanded on these methods and results in Chapter 4 to develop computational 
methods to identify differentially methylated peak regions (DMPRs). I discussed 
the impact of the efficiency of the IP, global changes in m6A levels, and 
normalizing for changes in mRNA transcript levels. I developed a method 
building on existing methods to identify differentially expressed genes in RNA-
sequencing data, using normalization factors to correct for technical variation in 
the IP. I compared the results with existing methods from exomePeak, though 
developing better methods of identifying DMPRs will require better validation.  
In Chapter 5, I applied the methods I introduced in earlier chapters to try to 
understand the physiological and functional role of methyl-6-adenosine. 
Building on previous work with Ribavirin treatments affecting nuclear export of 
RNAs, as well as the well-characterized heat shock response, I implemented 
an experimental design to compare m6A sites between total, nuclear, and 
cytosolic RNA. I first showed the results of the RNA-sequencing analysis, 
looking at differentially expressed genes and the up-regulation of the HSP70 
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gene family in response to heat shock. I then identified differentially methylated 
peak regions and found a correlation between methylation changes in intronic 
segments and the changes in the nuclear to cytosolic ratios of those genes, 
indicating that m6A could play a role in nuclear export.  
I then examined m6A in the porcine model, mapping its epitranscriptome for the 
first time. Specifically looking at two breeds of pigs, the fattier Jinhua and the 
leaner Landrace, I examined how m6A on the transcriptome level correlates with 
adipogenesis, identifying differentially expressed genes and differentially 
methylated genes and their associated gene ontology pathways.  
7.2 Future Directions 
Each month, new research unravels novel work in m6A, a field that is gaining 
more attention. Science has followed Francis Crick’s central dogma, focusing 
first on the genetic level, then building on the model to include epigenetic data, 
including histone modifications and DNA methylation, and now the world view 
is expanding to include the epitranscriptome. Whole ‘omics studies that examine 
all of them simultaneously are rare, and expensive, but are the future of the field, 
working to build a more complete model of the complex biological regulatory 
networks. The difficulty with m6A is that it is still a young field, most of which is 
still unknown. Each day we take small steps towards fully understanding its role, 
but without identifying all of the possible readers, writers, and erasers, we are 
still far from fully understanding the full functional relevance of m6A.  
Furthermore, DNA methylation patterns have been well-characterized in 
cancers, such as acute myeloid leukemia (AML),  (Figueroa et al., 2010), with 
genetic mutations in IDH1 and IDH2 affecting DNA methylation patterns by 
disrupting the oxidative decarboxylation of isocitrate to alpha-keto-glutarate. 
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Tet2 catalyzes the conversion of 5-methylcytosine to 5-hydroxymethylcytosine, 
dependent on alpha-keto-glutarate. The RNA demethylases, FTO and ALKBH5, 
are also dependent on alpha-keto-glutarate for their function, and consequently, 
susceptible to IDH1 and IDH2 mutations in cancers. Examining this connection 
would demonstrate the clinical significance of the epitranscriptome, though 
research is hindered by the RNA input limit. The ability to barcode RNA 
fragments and pool samples together could open that door.  
Lastly, in lieu of chemical-based methods to identify m6A sites, third-generation 
single-molecule sequencers may be the future in identifying RNA modification. 
Instead of sequencing complementary DNA, introducing PCR and GC-biases, 
the native RNA strand could be sequenced, simultaneously reading in all 
modification data. I demonstrated a proof of principle on the Pac Bio RS, 
showing that direct RNA sequencing is not only possible, but has the ability to 
discern m6A sites from adenosines. Oxford Nanopore Technologies’ minION 
sequencers are smaller and easier to work with, and could be the future of all 
sequencing. Despite their high error rate, the protocol has the same potential to 
detect m6A sites at single nucleotide resolution.  
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